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ABSTRACT
The neuroendocrine control of broodiness was investigated in the bantam
hen. The functional activity of hypothalamic monoaminergic neurones
and the role of vasoactive intestinal polypeptide were considered in
relation to the control of prolactin and luteinizing hormone (LH)
secretion.
The functional activity of hypothalamic noradrenergic neurones, based
on an index of turnover, did not change after the onset of incubation.
cv_
However, the functional activity of hypotha]£nic adrenergic neurones
was inversely correlated with pls^na levels of LH and positively
correlated with plasma levels of prolactin . This suggests that
adrenaline-containing neurones may be, in part, responsible for the
increase in plasma levels of prolactin and the decrease in plasma
levels of LH at the onset of incubation. Similarly the functional
activity of dopaminergic neurones in the anterior hypothalamus, but not
the posterior hypothalamus, was inversely correlated with plasma LH and
positively correlated with plasma prolactin.
Putative dopamine receptors were demonstrated in both the hypothalamus
and the pituitary gland. Hypothalamic putative dopamine receptors were
the same in laying and incubating birds. The density of putative
dopamine receptors was significantly lower in pituitary glands from
incubating birds than in those of laying birds. This suggests that any
direct inhibitory influence of dopaminergic neurones in the posterior
hypothalamus on prolactin secretion in incubating birds is reduced by
'down-regulation' of dopamine receptors in the anterior pituitary
gland.
The distribution of 5-hydroxytryptamine (5HT) containing neurones in
the brain-stem and hypothalamus was mapped using an immunohistochemical
technique. Extensive 5HT fibres and terminals originating from cell
bodies in the hind-brain and paraventricular organ were abundant
throughout the hypothalamus with the highest densities occu^ng in the
pre-optic area and basal hypothalamus. Putative 5HT receptors were
demonstrated in the hypothalamus but were absent from the anterior
pituitary gland. Within the anterior hypothalamus a unique population
of putative 5HT receptors was found only in the laying bird. This
population disappeared during the onset of broodiness. The
disappearance of this receptor population may be in part responsible
for an increase in the functional activity of 5HT neurones in the
anterior hypothalamus which was observed after the onset of incubation.
The functional activity of 5HT containing neurones in the posterior
hypothalamus did not change after the onset of incubation.
The possible role of hypothalamic 5HT-containing neurones in the
stimulation of prolactin secretion was investigated by assessing the
influence of various drugs known to alter 5HT function, on plasma
levels of prolactin. Although the drug studies suggested a strong
stimulatory influence of 5HT neurones on prolactin secretion when it
was measured in a homologous chicken radioimmunoassay these findings
were not confirmed when prolactin was measured in a heterologous
radioimmunoassay. Separation of the proteins present in various in
la. —
vitro incubations of pituitary glands and hypoth^ni by polyacrylamide
gel electrophoresis demonstrated that the homologous radioimmunoassay
cross-reacted with proteins of hypothalamic origin as well as prolactin
released from the pituitary gland. It was concluded that, although
5HT-containing neurones may be involved in the stimulation of a
tr\
prolactin releasing factor from the hypothalamus, their role ^the
neuroendocrine control of broodiness is limited.
In the hypothalamus a vasoactive intestinal polypeptide-like substance
was located immunohistochernically in neurones in the basal hypothalamus
which had an anatomical distribution consistent with a role in the
control of anterior pituitary gland function. Vasoactive intestinal
polypeptide stimulated selectively prolactin secretion when administerd
in vivo, and stimulated prolactin secretion from the isolated pituitary
gland. These observations suggest that endogenous hypothaijmic
vasoactive intestinal polypeptide is a specific prolactin-releasing
factor in the bantam hen. It is also suggested that the stimulation of
prolactin secretion associated with the hypothalamic monoamine
neurotransmitters may be mediated in part by vasoactive intestinal
polypeptide-containing neurones.
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1.0 INTRODUCTION
1.1 BROODINESS IN THE CHICKEN: PHYSIOLOGICAL AND BEHAVIOURAL
CORRELATES
In the chicken the periods of incubation and parental care , although
physiologically distinct (Saeki and Tanabe, 1954), are collectively
referred to as broodiness. Domestication and selective breeding for
increased egg production have reduced the incidence of broodiness in
commercial poultry. However, some heavy strains of laying hens,
broiler breeders and turkey hens still retain a broody tendency, albeit
reduced. The loss of egg production due to broodiness and the labour
intensive nature of the current treatments used to remedy broodiness
(Sharp, 1979) are considerable financial burdens on an otherwise
extremely efficient industry. A better understanding of the
neuroendocrine control of broodiness, as well as being of interest in
itself, may alleviate some of this burden by providing the basis for
rational remedial treatments for broodiness.
Several physiological and behavioural attributes distinguish the broody
from the laying hen. Towards the onset of incubation, follicles in the
ovary become atretic , egg production stops and the ovary and oviduct
regress. Also, because of their dependence on gonadal steroids, the
comb and wattles lose their bright red colour. In chickens a single
large brood patch develops at the onset of incubation in response to
the combined actions of prolactin and the gonadal steroids (Jones et
al. 1970). The hen's behaviour also changes at this time. Continuous
incubation is preceded by an increase in nesting at night which
progressively extends into the end of the light period (Lea et al.
1981). As incubation gets underway hens begin to display a
characteristically crouched posture, with the wings extended laterally,
while on the nest and during infrequent feeding trips off the nest.
Aggressive defence of the nest is also shown, accompanied by feather
erection, pecking and a 'clucking' call. After the eggs hatch, defence
of the chicks and foraging with the chicks are the predominant
behaviours. As the chicks become independent the hen's ovary and
oviduct gradually re—develop, the brood patch refeathers and laying
resumes.
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1.1.1 Prolactin and Broodiness
The first experimental evidence suggesting the involvement of prolactin
in broodiness was reported by Riddle, Bates and Lahr in 1935. They
found that "the full expression of broodiness" could be induced in
laying hens by injections of a crude chicken prolactin preparation.
Similar injections given to non-laying hens and laying hens of a
non-broody strain, resulted in clucking and care of chicks but not
incubation. Subsequent investigations demonstrated that homogenates of
pituitary glands from broody hens induced a bigger response in the
pigeon crop sac bioassay for prolactin than pituitary homogenates from
laying hens (Burrows and Byerley, 1936). This shows that pituitary
glands from broody hens contain more prolactin than pituitary glands
from laying birds. It has also been demonstrated that the pituitary
glands of hens brooding chicks contain less prolactin than those of
incubating hens (Saeki and Tanabe, 1954 , 1955). Early cytological
studies showed a change in the structure of both the caudal and
cephalic lobes of the anterior pituitary glands of broody hens (Payne,
1942 , 1943; Yasudo, 1953). Later it was demonstrated that the caudal
lobe of a pituitary gland from a broody hen contained as much, if not
more prolactin than the cephalic lobe while little prolactin was found
in the caudal lobe of pituitary glands from non-broody hens (Nakajo and
Tanaka, 1956).
The early studies of Riddle and Lahr (1944) on ring doves suggested
that, as in the chicken, prolactin is responsible for the initiation
of incubation. However, later observations did not support this view
since it was found that progesterone is more effective than prolactin
in inducing incubatory behaviour in this species (Lehrman, 1958;
Lehrman and Brody, 1961). Also, using the pigeon crop-sac
radioreceptor assay to measure prolactin, Buntin and Forsyth (1979)
found that pituitary levels of prolactin in ring doves do not rise
until after the onset of incubation. Recent radioimmunoassay evidence
confirmed this finding, demonstrating that plasma levels of prolactin
do not increase until after incubation has began (Goldsmith et al.
1981). Despite the uncertainty about prolactin's involvement in the
induction of incubation, its role in the maintenance of incubation and
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the parental care of the young in the ring dove is generally accepted
(Lehrman and Brody, 1964; Silver, 1978). Its specialised function in
promoting the development of the crop sac and production of crop 'milk'
in this species requires that prolactin secretion be delayed until near
the hatch of the squabs. As this is not the case in chickens, findings
based on experiments in the ring dove may be of questionable relevance
to the study of the role of prolactin in broodiness in the bantam hen.
Although, in contradiction to the early investigations, a recent study
found that a highly purified mammalian prolactin preparation failed to
induce broodiness when administrated to chickens and turkeys (Opel and
Proudman, 1980), the development of radioimmunoassays allowing the
measurement of plasma levels of prolactin, has firmly established the
involvement of prolactin in broodiness in poultry. Using a homologous
chicken radioimmunoassay (Scanes et al. 1976), Sharp et al. (1979)
observed a small but significant rise in plasma levels of prolactin
during incubation in bantam hens. A larger rise was observed in White
Rock hens using an improved homologous assay (Bedrak et al. 1981). Lea
et al. (1981) demonstrated a large rise in plasma levels of prolactin
around the onset of incubation in bantam hens. This rise was also
observed using a heterologous prolactin radioimmunoassay based on an
antiserum to human prolactin and ovine prolactin label developed in
1978 for birds by McNeilly et al. ( Lea et al. 1981; Lea, 1982).
Although no change in plasma levels of prolactin were apparent in the
broody turkey when measured in the homologous chicken assay (Harvey et
al. 1981) or the heterologous assay (Etches et al. 1979), large
increases in plasma levels of prolactin in broody turkeys have been
measured (Burke and Dennison, 1980; Lea and Sharp, 1982) using a
homologous turkey radioimmunoassay developed by Burke and Papkoff
(1980). The finding in the bantam hen, that plasma levels of prolactin
begin to rise prior to the onset of incubation suggests that prolactin
may play a role in the initiation of this behaviour (Lea et al. 1981).
In the bantam hen, in addition to a possible involvement in the
induction of incubation, prolactin is also involved in the maintenance
of this behaviour since injections of ovine prolactin maintain broody
behaviour in birds deprived of their nests (Sharp,P.J. and
Pedersen,H.C. unpublished observations).
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1.1.2 Luteinizing Hormone, Gonadal Steroids and Broodiness
In bantam hens plasma levels of luteinizing hormone (LH) and
progesterone are high when the birds are laying but fall quickly at the
onset of incubation (Sharp et al. 1979). The fall in plasma levels of
LH and progesterone is preceded by an increase in plasma levels of
prolactin at the onset of incubation (Lea et al. 1981). The inverse
relationship between prolactin and LH may be due to the ability of
prolactin to inhibit gonadotrophin secretion by inhibiting the release
of luteinizing hormone releasing hormone (Lea and Sharp, 1982). In the
turkey (Cogger and Burke. 1976; Cogger et al. 1979; Burke and Dennison.
1980) and chicken (Bedrak et al. 1981) plasma levels of LH,
progesterone and oestradiol decline before the onset of incubation.
Plasma levels of LH are rapidly restored following the removal of eggs
and/or chicks from broody birds of several species including bantam
hens (Sharp et al. 1979) and turkeys (Lea and Sharp 1982; Lea, 1982).
This increase in LH secretion may be a consequence of a decrease in
prolactin release since, as observed in turkeys, nest deprivation
results in a rapid fall in plasma levels of prolactin (El Halawani et
al. 1983).
From this evidence and assuming the appropriate environmental
conditions exist, the induction and maintenance of broodiness involves
a decrease in gonadotrophic activity, and consequently gonadal steroid
secretion, and an increase in prolactin secretion.
1.2 THE CONTROL OF THE PROLACTIN SECRETION.
The ability of anterior pituitary gland extract to induce lactation in
pseudo-pregnant rabbits was first demonstrated in the 1920's (Strieker
and Grueter ,1928). Similar findings coupled with the ability of
anterior pituitary gland extract to induce the formation of crop 'milk'
in pigeons led Riddle et al.(1933) to name this newly discovered
hormone prolactin. In the pigeon, acidophilic cells in the anterior
pituitary were identified as responsible for prolactin production
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(Schooly and Riddle, 1938), and in an early study structurally
comparable acidopt^Lic cells were also found in the fowl and mammalian
anterior pituitary gland (Rahn, 1939).
The chemical composition of avian prolactin, first isolated from
chicken (Scanes et al. 1975) and subsequently, turkey pituitary glands
(Burke and Papkoff, 1980; Proudman and Corcoran, 1981), is closely
related to that of ovine prolactin and is distinct from avian growth
hormone.
Intensive study has shown that prolactin has many different actions in
many species (Nicoll, 1974; Swearingen and Nicoll, 1974). These actions
affect aspects of reproduction, behaviour, osmoregulation, growth and
metabolism (de Vlaming, 1974). Much is known of the control of
prolactin secretion in mammals ( reviews : Neill, 1974; Tindal^f, 1974;
MacLeod, 1976; Meites, 1977; Boyd and Reichlin, 1978; Enjalbert et al.
1978; Lancranjan and Friesen, 1975; MacLeod and Scapagnini, 1980) while
less is known about its control in birds ( Harvey et al. 1982; Chadwick
and Hall, 1983) The purpose of this section is to discuss briefly the
control of prolactin secretion in mammals and birds.
1.2.1 The Control of Prolactin Secretion in Mammals.
In mammals, prolactin secretion is under the predominantly inhibitory
influence of the hypothalamus. The first indication of such an
inhibition was the report that rat anterior pituitary glands grafted
away from the hypothalamus retained their luteotrophic actions
(Desclin, 1950) and that pituitary transplants secreted prolactin
autonomously (Everett, 1954). Later research showed that hypothalamic
factors could inhibit prolactin release in vitro (Pasteels, 1962;
Ratner and Meites, 1964) and that they were present in hypophysial
portal blood in vivo (Kamberi et al. 1971). There is now general
agreement that the catecholamine, dopamine, is the major physiological
prolactin inhibiting factor in mammals(see Shaar and Clemens, 1974).
Dopamine released from the terminals of tubero-infundibular neurones
of the median eminence (Weiner and Ganong, 1978) into the hypophysial
portal blood inhibits the secretion of prolactin by the activation of
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specific dopamine receptors located on the prolactin producing cells of
the pituitary gland (Brown et al. 1976). There is evidence, however,
that dopamine is not the sole prolactin inhibiting factor in the
mammalian hypothalamus (Kordon and Enjalbert, 1980). Attempts to
isolate peptide prolactin inhibiting factors have not yet been
successful.
The existence of a prolactin-releasing factor in the mammalian
hypothalamus has been suggested (Nicoll et al. 1970; Valverde et al.
1972). Thyrotropin-releasing hormone (TRH) stimulates prolactin release
from cultured rat pituitary cells (Tashjian et al. 1971) and is
considered a possible releasing factor. However, prolactin release is
not impaired after passive immunisation with anti-TRH serum (Harris et
al. 1978). Several other peptides including, the opioid peptides
(Rivier et al. 1977; Wardlaw et al. 1980), bombesin, ranatensin, and
litorin (Rivier et al. 1978), arginine vasotocin (Johnson, 1978),
neurotensin and substance P (Rivier et al. 1977) and vasoactive
intestinal polypeptide (Ruberg et al. 1978) have been shown to
stimulate prolactin secretion. However, only vasoactive intestinal
polypeptide (VIP) stimulates prolactin secretion by a direct action on
the pituitary gland. The dose—response relationship between VIP and
prolactin secretion in vitro (Clemens et al. 1980), its localisation in
the hypothalamus (Samson et al. 1978) and its occurrence in higher
concentrations in hypophysial portal blood than in the peripheral
circulation (Said et al. 1978; Said and Porter, 1979) suggest that VIP
is a physiological prolactin releasing factor .
In mammals, prolactin exerts a negative feedback action on its own
secretion. This feedback occurs at the level of both the pituitary
gland (MacLeod and Abad, 1968; Nicoll, 1971; Herbert et al. 1979) and
the hypothalamus (Chen et al. 1967; Meites and Clemens, 1972).
Prolactin selectively increases the release of dopamine from the
terminals of the tubero-infundibular dopaminergic neurones, thus
inhibiting its own release (Hockfelt and Fuxe, 1972; Annunziato and
Moor, 1978; Gudelsky and Porter, 1980). Conversely, oestrogen
stimulates prolactin secretion in mammals by making the pituitary gland
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less sensitive to dopaminergic inhibition (Raymond et al. 1978) and by
exerting anti-dopaminergic effects in the hypothalamus (Euvard et al.
1979).
In addition to dopamine, other hypothalamic monoamines are also
involved in the control of prolactin secretion. Neurones in the
mammalian hypothalamus containing 5-hydroxytryptamine appear to have a
stimulatory role in the regulation of prolactin release in vivo (Lu and
Meites, 1973), and probably stimulate the release of a
prolactin-releasing factor (Clemens et al. 1975). The possible role of
noradrenaline in the control of prolactin secretion is less clear,
since inhibitory and stimulatory effects have been reported (Clemens
and Shaar, 1980). There is agreement, however, that noradrenaline does
not act directly on the pituitary gland and probably alters the balance
of inhibitory and stimulatory influences on prolactin secretion by a
hypothalamic mechanism.
Studies involving the electrical stimulation (Everett and Quinn, 1966;
Wuttke and Meites, 1972; Tindall and Knaggs, 1969; Peters and Gala,
1975) and ablation of localised areas of the hypothalamus (Wolinska et
al, 1977) support the view that the control of prolactin secretion in
mammals involves both inhibitory and stimulatory mechanisms (Domanski
and Polkowska, 1973). Inhibitory control appears to be mediated by the
lateral part of the medio-basal hypothalamus while stimulatory control
seems to be predominantly a function of the supra-chiasmatic region.
1.2.2. The Control of Prolactin Secretion in Birds
The control of prolactin secretion in birds differs fundamentally from
that in mammals in as much as the avian hypothalamus exerts a
predominantly stimulatory influence over the pituitary gland.
Supporting evidence for this comes from the findings that the pituitary
glands of pigeons (Tixier-Vidal and Gourdji, 1972) and chickens (Bolton
et al. 1974) do not maintain a large output of prolactin when incubated
in vitro. Also auto-transplantation and homo-transplantation of the
pituitary glands in chickens (Ma and Nalbandov, 1963) and pigeons
(Bayle, 1969; Bayle and Assenmacher, 1965) showed that prolactin
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secretion is not maintained when the influence of the hypothalamus is
removed. However, chicken pituitary glands do secrete small quantities
of prolactin when incubated in vitro (Harvey et al. 1982), suggesting a
small degree of autonomous secretion. The Peking Duck would seem to be
an exception amongst the species so far studied in that prolactin
secretion is maintained at a relatively high level in the medium of
cultures of pituitary cells from this species (Gourdji and
Tixier-Vidal, 1966; Tixier-Vidal and Gourdji, 1970).
Further evidence of a stimulatory role for the hypothalamus in the
control of prolactin secretion comes from the study of the effects of
hypothalamic extract on prolactin release. In vitro incubation of
pigeon (Kargt and Meites, 1965), duck (Gourdji and Tixier-Vidal, 1966),
tri-coloured blackbird (Nicoll, 1965), turkey(Chen et al. 1968), quail
(Tixier-Vidal and Gourdji, 1972) and chicken (Hall et al. 1975)
pituitary glands with hypothalamic extract results in a significant
increase in prolactin secretion. In vivo administration of hypothalamic
extract to pigeons stimulates prolactin secretion sufficiently to cause
crop sac development (Knight and Chadwick, 1975). Also, small amounts
of hypothalamic extract greatly elevate plasma levels of prolactin
within minutes of injection in both conscious and anaesthetised
chickens (Bolton et al. 1976; Chadwick et al. 1978; Harvey et al.
1979). The rise in plasma levels of prolactin is dependent on the dose
of hypothalamic extract administered (Harvey et al. 1979).
The ability of rat hypothalamic extract to inhibit the rise in plasma
levels of prolactin following the administration of chicken
hypothalamic extract to chickens (Bolton et al. 1976) raises the
possibility that prolactin secretion in the chicken may be, in part,
under inhibitory hypothalamic control. Since dopamine is a
prolactin-inhibiting factor in mammals it could also serve this
function in birds. In support of this view dopamine inhibits the basal
release (Harvey et al. 1982) and the stimulated release (Hall et al.
1975) of prolactin from chicken pituitary glands incubated in vitro .
Although dopamine is present in the chicken median eminence and
hypothalamus (Talbot et al. 1984), there is no evidence of a
dopaminergic system equivalent to the tubero-infundibular pathway
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described in mammals (Ikeda and Gotoh, 1971). However, the analogue has
been drawn between the avian paraventricular organ and the mammalian
tubero-infundibular system (Okshe ,1983).
Stimulation of prolactin release from the isolated chicken pituitary
gland by 5-hydroxytryptamine has been reported (Border and Chadwick,
1977), but this effect is much enhanced in pituitary-hypothalamus
co-incubations (Harvey et al. 1982). These findings suggest that
5-hydroxytryptamine acts predominantly through the hypothalamus to
release prolactin. In vivo, administration of 5-hydroxytryptamine
a
stimula-gfe prolactin secretion in the pigeon (Nistico et al. 1980).
Further , in cockerels, 5-hydroxytryptamine receptor agonists cause an
increase, while antagonists cause a decrease in plasma levels of
prolactin (Rabii et al. 1981). Noradrenaline also stimulates prolactin
release from the isolated chicken pituitary gland, and enhances
prolactin release in pituitary/hypothalamus co-incubations (Harvey et
al. 1982). Monoamine neurotransmitters would thus seem to exert a
predominantly stimulatory effect on prolactin secretion. However, when
chicken hypothalamic extract is treated with alumina to absorb
monoamines it loses only about 50% of its ability either to release
prolactin from the chicken pituitary gland in vitro, or to elevate
plasma levels of prolactin in chickens in vivo (Border, 1979). These
findings imply the existence of a non-monoaminergic prolactin releasing
factor in the chicken hypothalamus.
As thyrotrophin-releasing hormone (TRH) is a potent prolactin releasing
factor in mammals, its possible physiological significance in the
control of prolactin secretion in birds has been studied. Initial
investigations demonstrated that TRH stimulates prolactin secretion
from chicken and pigeon pituitary glands, incubated in vitro (Bolton et
al. 1974; Chadwick and Hall, 1975; Hall et al. 1975). Hall et al.
(1975) found that TRH stimulated both prolactin and growth hormone
release from pigeon pituitary glands and that this effect is inhibited
by dopamine. Using the homologous chicken radioimmunoassay, the
stimulatory effect of TRH on prolactin release from isolated chicken
pituitary glands was confirmed, but was not apparent in vivo (Harvey et
al. 1978a). Also, the—administration of—anti-TRH—oorum—to—pigeons
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reoultod in a proliferation of the crop anc muco3a (Shani ct al. 1900),
while the administration of anti-TRH serum to incubating bantam hens
had no effect on plasma levels of prolactin measured by
radioimmunoassay(Macnamee,M.C.and Sharp,P.J. unpublished observations).
Further, electrical stimulation of the pre-optic region of the pigeon
hypothalamus results in a stimulation of crop sac growth which is not
mimicked by injections of TRH (Kanematsu, 1980). The reconciliation of
these apparently contradictory findings awaits further investigation.
The observation that the concentration of TRH estimated in chicken
hypothalamus is too low to account for all the prolactin-releasing
activity of hypothalamic extract, suggests that TRH is not the sole
prolactin releasing factor in birds (Jackson and Reichlin, 1974).
Another potent prolactin-releasing factor in mammals is vasoactive
intestinal polypeptide (VIP). Four amino-acid substitutions
differentiate mammalian VIP from VIP isolated from chicken gut
(Nilsson, 1974,1975). Although chicken VIP has been demonstrated to
have biological actions on the gastro-intestinal tract (Dimaline and
Dockray, 1979) and a VIP-like substance has been immunohistochemically
localised in the quail hypothalamus (Yamada and Mikami, 1982), there
has been no investigation of a possible physiological role for VIP in
the regulation of prolactin secretion in birds.
<xcn
The effects of oestrogen on prolactin release in birds similar to
those in mammals. Oestrogen treatment stimulates prolactin release from
the isolated chicken pituitary gland, and enhances prolactin release in
pituitary/hypothalamus co-incubations (Hall and Chadwick, 1978).It also
elevates plasma levels of prolactin in non-laying, but not in laying
turkey hens (McNeilly et al. 1978).
Although there are some general similarities in the ways in which
prolactin secretion is influenced in birds, there seem to be important
species and strain differences. For example the rise in plasma
prolactin associated with oestrogen treatment in turkeys (McNeilly et
al. 1978), does not occur in the bantam hens (Sharp,P.J. Sterling,R.
and Macnamee,M.C., unpublished observations). Further, turkeys and
chickens seem to respond differently to photostimulation in terms of
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prolactin secretion (Lea, 1982), and the pre-ovulatory surge of LH is
accompanied by a decrease in plasma levels of prolactin in the chicken
but not in the turkey(Opel et al. 1983).
1.3 THE CONTROL OF LUTEINIZING HORMONE SECRETION IN BIRDS.
As was previously suggested (section 1.1), an inverse relationship
exists between prolactin and luteinizing hormone (LH) secretion. This
relationship is apparent in the bantam hen at the onset of incubation
(Lea et al. 1981)and during nest deprivation (see section 4.1.1.), and
also occurs during the reproductive cycle in mallards (Goldsmith and
Williams, 1980). It was also observed in the hen during the ovulatory
cycle where the pre-ovulatory LH surge is associated with a rapid fall
in plasma levels of prolactin (Scanes et al, 1977). In mammals, there
is a similar reciprocal relationship between LH and prolactin. Thus,
during suckling, prolactin secretion rises and LH secretion falls.
These hormonal changes are correlated with an increase in the turnover
of 5-hydroxytryptamine in the hypothalamus (Meites and Sonntag, 1981).
The reciprocal relationship between prolactin and LH in birds suggests
an interaction between the mechanisms controlling their secretion. The
purpose of this section is to summarise briefly the factors which
influence the secretion of LH in the chicken.
The central role of the avian hypothalamus in the regulation of LH
secretion is well established (Sharp, 1983). The distribution of the
decapeptide luteinizing-hormone-releasing-hormone (LHRH) within the
chicken hypothalamus has been described (Jozsa and Mess, 1982; Sterling
and Sharp, 1982) and two forms of specific chicken LHRH have been
isolated (King and Miller, 1982; Miyamoto et al. 1982 , 1983; Miller
and King, 1983). The secretion of LH is primarily controlled by the
activity of the LHRH system, which is influenced by other neural
inputs, which in turn are influenced by external stimuli and stimuli
resulting from the activity of hypothalamo-pituitary-gonadal system.
-12-
Three components involved in the control of LH secretion have been
identified; a direct steroid-independent 'hypothalamic drive', a
steroid negative feedback and a steroid positive feedback system
(Sharp, 1983).
In the mature bird the steroid-independent mechanism is based on
complex interactions of environmental factors (Murton and Westwood,
1977). Changes in its activity directly influence the function of the
LHRH system and may be responsible for the initiation and termination
of breeding. At all stages of the breeding cycle the control of LH
secretion is also influenced by steroid feedback mechanisms.
Increases in LH secretion have been reported following gonadectomy in
many avian species including chickens (Sharp, 1975; Wilson and Sharp,
1976), which—is consistent with a negative influence of gonadal
steroids on LH secretion. Also numerous studies have shown that the
administration of gonadal steroids inhibits gonadotrophin secretion
(Sharp, 1980). Wilson and Sharp (1976) found that oestrogen, and to a
lesser extent, progesterone administration depressed LH release in
ovariectomized hens and that a greater suppression of LH secretion is
achieved by their combined administration rather than the sum of their
individual effects. The pituitary gland is the major site for this
inhibitory feedback. As the ovary develops, and plasma levels of the
ovarian steroids increase, the response of the pituitary to LHRH
decreases significantly (Wilson and Sharp, 1975). Also oestradiol can
directly inhibit LH release and antagonize the action of LHRH on
pituitary cells in culture (Bonney and Cunningham, 1977; Luck and
Scanes, 1980).
The positive feedback influence of the gonadal steroids is concerned
with the regulation of the preovulatory release of LH. In a cascade
mechanism, an increase in circulating LH stimulates the secretion of
ovarian steroids which in turn stimulates further LH release (Sharp,
1980). Progesterone is the most likely positive feedback steroid in the
hen (see Sharp, 1983). However, progesterone injections fail to trigger
LH release in ovariectomised hens unless the birds are pre-treated for
several days with both oestrogen and progesterone (Wilson and Sharp,
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1976). This observation shows that the positive feedback stimulation of
LH secretion involves both oestrogen and progesterone during the
"priming" phase, and only after the positive feedback mechanism is
primed can an increase in circulating levels of progesterone trigger
the preovulatory surge of LH. The priming effect of oestrogen is
thought to be due to its stimulatory effect on the formation of
progesterone receptors ( Sharp, 1983). Both cytoplasmic and nuclear
progesterone receptors occur in the hypothalamus and pituitary gland of
the hen (Kawashima et al. 1978 ,1979a). The concentrations of these
cytoplasmic receptors change during the ovulatory cycle (Kawashima et
al. 1979b) in such a way as to suggest their involvement in the effects
of progesterone in the preovulatory release of LH. However ,it has been
recently demonstrated that LHRH cells in the chicken hypothalamus do
not contain nuclear progesterone receptor material (Sterling et al.
1984). This, together with the rapidity with which progesterone can
stimulate LH secretion (Wilson and Sharp, 1972), suggests that
progesterone acts on the LHRH system directly, or through an effect on
other neurones of^/as yet unidentified type, which contain nuclear
progesterone receptor.
The current understanding of the role of monoamines in the control of
gonadotrophin secretion is based on correlations between hypothalamic
monoamine content and changes in reproductive activity, and the effects
of pharmacological manipulation on LH release. Pharmacological
treatments in quail have demonstrated that noradrenaline stimulates,
while both dopamine and 5-hydroxytryptamine inhibit,
photoperiodically-induced testis growth (El Halawani et al. 1975
,1978). Evidence that these transmitters are involved in the control of
LH secretion comes from studies involving the measurement of plasma LH
levels rather than testicular growth (El Halawani et al. 1980a).
Pharmacological studies on juvenile hens confirm the stimulatory effect
of noradrenaline and the inhibitory effect of both dopamine and
5-hydroxytryptamine on LH secretion(Buonomo et al. 1981; Buonomo and
Scanes, 1983). In sum these observations suggest the involvement of
noradrenergic neurones in the stimulation, and dopaminergic and 5HT
neurones in the inhibition, of the non-steroid dependent control of LH
secretion.
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In the turkey, the post-castration rise in plasma levels of LH is
accompanied by an increase in the concentration and turnover of
noradrenaline in the hypothalamus (El Halawani et al. 1980b) In the
chicken, the rise in plasma levels of LH after ovariectomy is
accompanied by increased concentrations of dopamine and noradrenaline
in the medio-basal hypothalamus and increased concentrations of
noradrenaline and adrenaline in the anterior hypothalamus (Knight et
al. 1981). These findings suggest the inhibitory feedback of the
gonadal steroids may be due to their effect on catecholaminergic
neurones in the hypothalamus.
The progesterone-induced release of LH in the hen is also accompanied
by changes in the concentrations of monoamines in the hypothalamus,
with both dopamine and noradrenaline concentrations increased in the
pre-optic region (Knight et al. 1982). The spontaneous preovulatory
surge of LH in the hen is associated with a decrease in the turnover of
both 5-hydroxytryptamine and dopamine in the hypothalamus (Talbot et
al. 1984). These findings suggest the involvement of both
catecholaminergic and 5HT neurones in the hypothalamus in the positive
feedback action of the gonadal steroids on LH release.
In the reproductive cycle of the bantam hen egg production terminates
with the onset of incubation. The finding that injection of synthetic
mammalian LHRH increased plasma levels of LH in incubating bantams
(Sharp and Lea, 1981), suggests that LH secretion may be suppressed
because of a reduction in the secretion of endogenous LHRH. The
evidence presented above suggests that such a reduction may be brought
about by changes in the activity of hypothalamic monoaminergic
neurones.
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1.4. THE BIOCHEMISTRY OF MONOAMINE NEUROTRANSMITTER SYNTHESIS AND
METABOLISM
Monoaminergic neurotransmission in the avian brain has been implicated
in the control of gonadotrophin and prolactin secretion in birds (see
section 1.2 and 1.3). The purpose of this section is to review briefly
the current understanding of the biochemistry of monoamine
neurotransmitter synthesis, storage and metabolism, which forms the
basis of the estimation of hypothalamic monoamine functional activity
in the present work (section 4).
1.4.1. The Catecholamines
Knowledge of the cellular sites and mechanisms of synthesis, storage
and release of the catecholamine neurotransmitters derived from
studies of adrenergically innervated organs and adrenal medullary
tissue. The pathway of catecholamine synthesis (Figure 1) was
originally suggested by Blaschko (1939) and Holtz (1939), but the
complete pattern of anabolism was not demonstrated until Gurin and
Delluva (1947) gave radio-labelled phenylalanine to rats and recovered
radio-labelled adrenaline from the adrenal glands.
Catecholamine synthesis occurs in all parts of the adrenergic neurone,
the three principal enzymes involved in noradrenaline synthesis;
tyrosine hydroxylase, DOPA-decarboxylase, and dopamine-B-hydroxylase,
being present in the cell body, and in both the non-terminal and
terminal sections of axons (Goodall and Kirshner, 1958; Goldstein et
al. 1972). Tyrosine hydroxylation and DOPA-decarboxylation occur in the
axoplasm while B-hydroxylation of dopamine occurs solely in the
adrenergic storage organelles (Weiner 1970; von Euler, 1972). The
enzyme catalysing the conversion of noradrenaline to adrenaline,
phenylethanolamine-N-methyltransferase (PNMT) although predominantly
located in the adrenal glands, is also present in the axoplasm of some
adrenergic neurones in the brain (Axelrod, 1966; Goldstein et al.
1972).
-16-
Figure 1: The biosynthesis of catecholamines in adrenergic neurones.
Within the adrenergic neurone (a) 1—tyrosine is converted by tyrosine
hydroxylase (1) to 1-DOPA, which is converted by aromatic amino acid
decarboxylase (2) to dopamine. Within the storage granule (b), dopamine
may be converted to noradrenaline by the action of
dopamine-p-hydroxylase (3). Adrenaline can be produced by the action of
phenethanolamine-N-methyl transferase (4) on cytoplasmic noradrenaline.
Catecholamines released by exocytosis following nerve stimulation (6)
are taken up by the neurone (7) for restorage or metabolism. Most
intraneuronal metabolism is carried out by the mitochondrial enzyme
monoamine oxidase (c). The enzyme T-OH is subject to end product
inhibition (5).
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The hydroxylation of tyrosine is the rate-limiting step in the
synthesis of the catecholamines (Spector et al. 1963; Levitt et al.
1965; Udenfriend, 1966). The activity of tyrosine hydroxylase in nerve
terminals is subject to end product inhibition (Nagutsu et al. 1964;
Spector et al. 1967; Weiner, 1970), with noradrenaline competing for
its pteridine cofactor, providing a fast-feedback regulation of
catecholamine synthesis. Long-term changes in the rate of catecholamine
synthesis are achieved by regulation of the synthesis of
tyrosine-hydroxylase, which is dependent on neuronal activity (Axelrod
et al. 1970; Thonen, 1970; Thonen et al. 1970 , 1971; Bhatnagar and
Moore, 1972). The metabolic degradation of tyrosine hydroxylase is
slow, with a half-life of at least 8 days (Meuller et al. 1969). So, by
short-term end product inhibition and by control of tyrosine
hydroxylase synthesis, the synthesis of the catecholamine
neurotransmitters can be adapted to changes in the patterns of neural
activity.
The biological effects of catecholamines released from the adrenergic
neurone are terminated largely by reuptake to axons and other cells
surrounding the synapse (Iversen, 1971). Once inside the cell,
catecholamines which have been re-uptaken can be stored or metabolised.
The continuous degradation of catecholamine neurotransmitters occurs in
a wide variety of tissues and is performed by the combined actions of
monoamine oxidase and catechol-O-methyl transferase (Axelrod, 1966;
Kopin, 1972; Sharman, 1972). Monoamine oxidase is a generic term for a
group of enzymes which catalyse the oxidative deamination of monoamines
(see Blaschko, 1972) which are located within the double outer membrane
of mitochondria (Snyder et al. 1965; Tipton, 1967; Jarrott, 1971a). At
least two, functionally different, monoamine oxidase enzymes have been
identified, both of which occur in rat brain (Youdini et al. 1983).
Catechol-O-methyltransferase is widely distributed in many tissues.
However, only a relatively small amount is found in the cytoplasm of
adrenergic neurones (Jarrot, 1971b; Klingman and Klingman, 1972 a and
b). In normal circumstances monoamine oxidase and catechol-O-methyl






















Figure 2: The metabolic pathways of the catecholamine neurotransmitters.
All catecholamines are liable to metabolism by both monoamine oxidase
(MAO) and catechol-O-methyl transferase (COMT). Substance detectable by
electrochemical detection after HPLC (see section 2.4) are marked by *.
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1.4.2. 5-Hydroxytryptamine
5-hydroxytryptamine was identified in the mammalian brain in 1953
(Twarzog and Page, 1953; Amin et al. 1954) and in the avian brain in
1956 (Correale, 1956; Bogdanski et al. 1963). Since then compelling
evidence has accumulated suggesting that 5-hydroxytryptamine serves as
the neurotransmitter substance of a distinct class of neurones (Chase
and Murphy, 1973). The synthetic pathway for 5-hydroxytryptamine from
dietary L-tryptophan has been demonstrated (Udenfriend, 1959) and is
shown in figure 3.A. The enzymes concerned are tryptophan hydroxylase
and dopamine-B-decarboxylase (more correctly termed aromatic amino acid
decarboxylase). The hydroxylation of tryptophan takes place in the
cytoplasm and the decarboxylation of 5-hydroxytryptophan is confined to
the storage organelles (Bogdanski et al. 1957). The rate limiting step
in this pathway is the hydroxylation of L-tryptophan and the enzyme
tryptophan hydroxylase is subject to end-product inhibition. The
factors governing its synthesis are similar to those regulating the
synthesis of tyrosine hydroxylase in the adrenergic neurone (Macon et
al. 1971; Carlsson and Lindqvist, 1972; Glowinski et al. 1972). The
biological effects of released neuronal 5-hydroxytryptamine are
terminated by re-uptake into the pre-synaptic neurone and other cells
around the synapse where it can be metabolised only by the
mitochondrial enzyme monoamine oxidase. Unlike the catecholamine
neurotransmitters, 5-hydroxytryptamine is not a substrate for
catechol-O-methyl transferase. The products of monoamine oxidase action
on 5-hydroxytryptamine are shown in figure 3.B.
1.4.3. Functional Activity of Monoaminergic Neurones
The rate of monoamine neurotransmitter synthesis is dependent on the
rate of hydroxylation of tyrosine for synthesis of the catecholamines
and tryptophan for the synthesis of 5-hydroxytryptamine. In the
short-term, the rate of monoamine neurotransmitter synthesis is
regulated by end-product inhibition of tyrosine and tryptophan
hydroxylase, which maintains the amount of transmitter in the neurone
at a constant level. Longer-term adaptive changes in the rate of
transmitter synthesis are governed by factors influencing the synthesis
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Figure 3: A; the synthesis of 5-hydroxytryptamine (5HT). Dietary
1-tryptophan, once in the tryptaminergic neurone (a), is converted by
tryp,ofman hydroxylase (1) to 5-hydroxytryptophan (5HTP). In the storage
granule (b), 5HTP is converted to 5HT by aromatic amino acid
decarboxylase(2). Released 5HT is reuptaken to the neurone where it can
be metabolised by monoamine oxidase (3).
B; the metabolic pathway of 5HT. Monoamine oxidase (MAO) acts on 5HT to
produce the unstable intermediary 5-hydroxyindole-3-acetaldehyde which
is rapidly dehydrogenated to 5HIAA. 5HT, 5HTP and 5HIAA were measured
by electrochemical detection after HPLC.
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of these enzymes. The mechanism of change^ in the rate of synthesis of
the hydroxylases is activated by changes in neuronal activity
(Burnstock and Costa, 1975; Hamon et al. 1977). The rate of synthesis
of the monoamine neurotransmitter therefore reflects the functional
activity of the monoaminergic neurone.
Several methods have been developed to estimate the turnover of the
catecholamines in mammals. These include, a) the rate of disappearance
of a radio-labelled amine after administration of the amine itself
(Brodie et al. 1966; Costa and Neff, 1966), or of a radiolabelled
precursor (Udenfriend and Zallman-Nirenberg, 1963; Burack and
Draskoczy, 1964); b)the rate of disappearance of endogenous amines
after synthesis inhibition (Brodie et al. 1966; Costa and Neff, 1966;
Anden et al. 1969; Neff et al. 1969); c) the accumulation of
radio-labelled amines after administration of labelled amino acids
(Gordon et al. 1966; Neff et al. 1969); and d) the ratio of
catecholamine metabolites formed (Carlsson and Lindqvist, 1963;
Sharman, 1969). In the turkey, both the decrease in concentration of
hypothalamic monoamines after blockade of synthesis (El Halawani et al.
1980b) and the accumulation of monoamines after inhibition of monoamine
oxidase (El Halawani and Burke, 1976) have been used to estimate
monoamine turnover rates.
Most of these methods involve pharmacological intervention in the
normal functioning of the neurone and may therefore activate the
adaptive mechanisms controlling monoamine synthesis discussed earlier
(Malmfors, 1965; Presson and Waldeck, 1970). However, this does not
limit their usefulness in comparative studies as the possible
activation of such mechanisms would occur in all situations.
1.5. NEUROTRANSMITTER RECEPTORS
A chemical link in neurotransmission was first suggested at the turn of
the century, when it was noted that the effects of injections of
extracts of the adrenal glands bore a close resemblance to the
stimulation of sympathetic nerves (Lewandowsky, 1898; Langley, 1901).
The first real proof of the chemical mediation of nervous impulses was
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supplied by Loewi (1921), who demonstrated that the perfusate of an
isolated frog heart during vagal stimulation contained a substance
which could slow the beat of another, non-stimulated, frog heart.
Since then, overwhelming evidence supporting the theory of neurohumoral
transmission has accumulated (Koelle, 1975). The theory of neurohumoral
transmission holds that nerve impulses elicit responses in the
innervated structure through the liberation of specific chemical
substances. This involves the combination of the released chemicals
with specific receptor sites, which are coupled to the biological
machinery which can create a biochemical change in the target cell upon
activation. The purpose of this section is to outline the development
of receptor theory and the current understanding of receptor
regulation.
1.5.1. Receptor Theory - Historical Development
Modern receptor theory originated from observations made at the turn of
the century on the mode of action of drugs . Early speculation that the
physiological actions of drugs were due to a chemical reaction between
the drug and some constituent of the cell was supported by the work of
Langley (1878) on the antagonism between atropine and pilocarpine on
muscle contraction. Some years later, Erlich (circa 1897) suggested the
existence of chemical 'side-chains' on cells to explain the binding of
toxins. He distinguished between the toxophore group of toxins, which
gave it its toxic properties, and the haptophore group which chemically
bonded to 'side-chains' on the cell allowing the toxophore group to
exert its action (see Himmelweit, 1956-1960). After demonstrating the
direct action of nicotine on striated muscle, and that even in the
absence of a nerve supply its actions could be antagonised by curare,
Langley (1905) postulated that both drugs compete for a single
'receptive substance' on the muscle cell. Langley (1905) also suggested
that the normal function of this 'receptive substance' was to transmit
a stimulus from the nerve to the muscle.
The impact of the receptor theory developed by Ehrlich and Langley was
very limited in their lifetimes. The interaction of drugs and receptors
did not receive any sort of quantitative expression until the work of
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Clark and Gaddum in the 1920's and 1930's (Clark, 1926 a ,b; Gaddum,
1926 ,1937). Clark's work on the effects of atropine and acetylcholine
at the neuromuscular junction led to the realisation that receptors
were present in very small numbers and were most likely located on the
cell membrane. Subsequent work using muscarine, atropine and nicotine,
suggested the existence of two acetylcholine receptors, the so called
'muscarinic' and 'nicotinic' receptors. Similarly, study of the
differential effects of adrenaline-like substances on the
cardio-vascular system led Alquist (1948) to postulate the existence of
two types of adrenoceptor, the alpha and beta receptors. Although the
idea that one substance could produce opposite effects depending on the
type of receptor on which it acted, met with much resistance at the
time (see Alquist, 1973), it has subsequently proven to be of great
sympathomimetic substances. The discovery of receptor sub-types, often
with discrete localisation and mediating contrasting effects, led to
the study of structure-activity relationships and the discovery of many
specific agonists and antagonists for various receptors.
1.5.2. Current Models of Receptor Activation
The availability of specific receptor ligands and the advent of direct
receptor measurement (Pert and Snyder, 1973), have allowed the detailed
study of receptor types in the central nervous system and the
definition of an increasing diversity of receptor sub-types (Creese,
1981; Haigler, 1981; Minneman, 1981). These developments also provide
information on the mechanisms which translate receptor activation into
intra-cellular effects.
value in and quantification of the effects of
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The main steps in the pharmacodynamic phase of action of bioactive




The initial step, involving the interaction of the ligand with the
receptor site, is quantified by application of the law of mass














Where L is the ligand, R is the receptor in its non-activated state, R*
the receptor in the activated state, and R the receptor in a
non-receptive state. The equilibrium constants governing the relative
amounts of the different states are represented by K^. The receptor
complex LR* and the R* receptor contribute to the events leading to the
effect. The R state is included to explain such phenomena as
tachyphylaxis and specific desensitisation after repeated exposure to
the ligand.
In the case of rapid receptor regeneration, equation 1 can be reduced
to that for the occupation-activation model of receptor function
(equation 2), which is closely related to the classical
Michaelis-Menton equation for substrate-enzyme interaction (Ariens and
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The stimulus generated is postulated to be proportional to the fraction
of the receptors in the activated state (LR*). The alternative 'rate'
model of receptor activation holds that the stimulus generated is
proportional to the rate of receptor occupation (K^) (Paton, 1961).
The occupation-activation model seems to be adequate for the
explanation of most cellular interactions with endogenous transmitters.
However, in this model the receptor is regarded as a single
non-interactive entity, which may not be the case. Competitive
antagonists at the alpha-adrenergic , H^-histaminic, cholinergic,
dopaminergic and 5HT receptors are predominantly hydrophobic, whereas
the appropriate agonists are polar in nature. Study of the
structure/activity relationship between these compounds clearly
indicates that the antagonists predominantly bind to sites accessory to
those for the corresponding agonists (Ariens et al. 1964 ; Ariens and
Simonis , 1976). These findings have led to increasingly complex
theories of receptor activation (Changeaux et al. 1967 ; Pert and
Snyder , 1974;Cuatrecasas et al. 1975 ; review: Hollenberg ,1978).
Receptor activation usually triggers a secondary cascade of responses
(the amplifier system) possibly by an allosteric interaction with other
membrane components (Cuatrecasas, 1974).Stimulation of some receptors,
such as the nicotinic cholinergic receptor, directly alters ionic
gradients by affecting the properties of membrane ion channels (Heidman
and Changeux, 1978). However, in many cases receptor activation causes
a change in the intracellular level of a 'second messenger' substance.
Membrane bound adenylate cyclases which are stimulated to produce cAMP
by the specific activation of dopamine receptors (see Creese, 1981),
^-adrenoceptors (see Minneman, 1981) and 5HT-receptors (see Fillon,
1983), have been described. Although alpha-adrenoceptor activation
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has been demonstrated to influence intracellular cAMP formation, the
effect is not consistent between all alpha-adrenoceptors. Other
possible second messengers at these sites include calcium ions and the
membrane lipid, phosphatidylinositol (Minneman, 1981). So it appears
that a variety of second messengers can be produced by receptor
activation and that a given receptor type is not always associated with
the same second messenger.
Generally ,the second messenger can act directly, or through a further
cascade process, to affect the activity of appropriate metabolic
enzymes or the expression of particular genes (both possible effector
systems in diagram above), to bring about a change in the activity of
the cell.
Regulation of the process outlined in the above diagram is possible at
any of the individual steps. The quantal relationship between receptor
activation and the intracellular response may be altered to allow
physiologically adaptive processes to occur. Also, and of prime
importance in the present context, are the ways in which the
combination of ligand and receptor may be subject to regulation.
Control exercised at this level would also allow adaptive changes to
occur in the post-synaptic cell,and could result in the differential
secretion of a given hormone.
1.5.3. Receptor Regulation
Receptor regulation has been the subject of many recent reviews (e.g.
Hollenberg, 1979; Fambrough, 1980; Chuang et al. 1984). Most reviewers
identify two factors which may predominate in influencing the dynamics
of receptor turnover in vivo : the influence of neurotransmitter
activity and the influence of steroid hormones.
The phenomena of hypo- and hyper-sensitivity of excitable cells are
well documented (see Fleming, 1976). These phenomena occur in response
to chronic changes in stimulation as for example in the rat where an
increase in the activity of noradrenergic input to the cerebral cortex
has marked effects on B-adrenoceptor density (Sporn et al. 1977).
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studies on the rat also provide examples of the influence of steroids
on neurotransmitter function. For example, in ovariectomised rats,
oestrogen treatment increases the levels of putative hypothalamic
p-adrenergic, muscarinic, cholinergic and 5HT receptors (McEwen and
Parsons, 1982). Dopamine receptors in the striatum of ovariectomised
rats also increase after oestrogen treatment (Hruska and Silbergeld,
1980) and similarly, dopamine receptors in the pituitary gland are
under oestrogenic control (Heiman and Ben-Jonathan, 1982).
The mechanisms by which these changes occur may alter the availability
of receptors in the cell membrane in a number of ways. Receptor
formation may be induced via a genomic action (McEwan and Parsons,
1982) or alternatively, receptor turnover may be related to alterations
in the fluidity of the cell membrane (Heron et al. 1980).
These possible mechanisms controlling receptor regulation are
additional means, apart from the regulation of neurotransmitter
turnover, by which the functional activity of a given neurone system
may be changed, and may be in part responsible for the endocrine
changes associated with broodiness.
1.6. ANATOMICAL CONSIDERATIONS IN THE CONTROL OF ANTERIOR PITUITARY
GLAND FUNCTION IN BIRDS
Any consideration of the mechanisms controlling hormone release from
the anterior pituitary gland must take into account the anatomical
organisation of the hypothalamo-hypophysial system. The purpose of this
section is to summarise briefly the salient anatomical features of the
avian hypothalamo-hypophysial complex with particular influence on the
secretion of prolactin and luteinizing hormone.
1.6.1. The Link between the Hypothalamus and Pituitary Gland
The hypophysial portal system was first described in mammals by Popa
and Fielding (1930). They observed a system of capillaries in the
median eminence which united to form vascular trunks in the pituitary
-28-
stalk and broke up again into sinusoid capillaries in the anterior
pituitary gland. The functional significance of this system was first
realised by Harris (1948), who suggested that chemical mediators
produced in the brain were transported by the hypophysial portal blood
supply to influence specific aspects of anterior pituitary gland
function. The hypophysial portal vasculature is now generally accepted
as being the final link between the brain and anterior pituitary gland
(review : Everett, 1978).
The avian hypophysial portal system has been described in the chicken
(Green, 1951; Hasegawa, 1956) and reviewed by Mikami (1980). In birds
the infundibular artery supplies the almost independent capillary
plexus, corresponding to the anterior and posterior divisions of the
median eminence, which converge to form the anterior and posterior
groups of portal vessels. The anterior portal vessels, originating from
the anterior median eminence, supply the sinusoids of the cephalic lobe
of the anterior pituitary gland, while the posterior portal vessels,
from the posterior median eminence, supply the sinusoids of the caudal
lobe of the anterior pituitary gland.
1.6.2. Prolactin and Luteinizing Hormone in the Anterior Pituitary
Gland.
The development of immunohistochemical techniques has permitted the
identification and characterisation of cell types in the anterior
pituitary of birds on the basis of the hormones they contain. The
application of this technique shows that prolactin containing cells
occur in the cephalic lobe of the anterior pituitary gland (McKeonin,
1972; Marchand et al. 1975; Hansen and Hansen, 1977), while
LH-immunoreactive cells occur in both the caudal and cephalic lobes
(Marchand and Sharp, 1977). Recently it has been demonstrated that many
LH-immunoreactive cells contain FSH-immunoreactivity (Mikami, 1983).
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1.6.3. The Avian Median Eminence
The median eminence consists of three layers, an inner ependymal layer
an intermediate fibre layer and an outer palisade layer. The primary
capillaries of the hypophysial-portal system are predominantly located
at the surface of the median eminence, rarely penetrating the inner
layers (Benoit and Assenmacher, 1951). Within the median eminence
specialised ependymal cells (tanycytes) form a functional link between
the third ventricle and the hypophysial portal vessels (Knigge and
Silverman, 1972; Kobayashi et al, 1972). The major innervation of the
median eminence is supplied by axons originating in two distinct
regions of the hypothalamus. Classically, the anterior median eminence
receives fibres mainly from the magnocellular neurosecretory cells of
the paraventricular, supraoptic and pre-optic regions via the
hypothalamo-hypophysial tract, while the posterior median eminence is
mainly innervated by fibres from the nucleus infundibularis via the
tubero-hypophysial tract (Oksche and Farner, 1974). Although^LHRH cells
txfe. -+v€.
/in the anterior hypothalamus (Sterling and Sharp ,1982), and/VIP cells
aV bow
/in the posterior basal hypothalamus/ innervate anterior—and—posterior
"barV
mndiaa—aninonoo—innervate—b©th/parts of the median eminence (section
7).
A rich monoaminergic innervation of the median eminence has been
described ( Calas et al. 1974) and numerous neuro-endocrine peptides
have been localised in nerve terminals in the median eminence (see
Blahser, 1983). The anatomical diversity of input to the median
eminence and the neurochemical diversity of substances are consistent
with an integrative function in the control of anterior pituitary
function.
1.6.4. The Hypothalamus
The avian hypothalamus is heavily innervated by both monoaminergic and
peptidergic neurones (Oksche, 1983) which may be directly or indirectly
involved in the regulation of neuroendocrine function.
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Primary control of LH secretion resides in the LHRH neuronal system
which has been described in the chicken by Sterling and Sharp (1982)
and Jozsa and Mess (1982). The cell bodies of this system are
principally located in the anterior hypothalamus close to the midline.
Fibres from these cells pass through the basal hypothalamus to
terminate in the external layer of the median eminence. The neurone
system primarily concerned with the stimulation of prolactin secretion
o
has not yet been identified, although evidence cited in sectj/n 1.2.
suggests that the avian prolactin - releasing factor is not a
monoamine.
The only major grouping of monoamine containing cells intrinsic to the
avian hypothalamus occurs in the paraventricular organ (Sharp and
Follett, 1968). These cells, which are thought to possess sensory
function, are exposed to the cerebrospinal fluid of the third
ventricle, and contain dopamine and 5-hydroxytryptamine (Vigh and
Vigh-Teichmann, 1973). Neuronal projections extending from the
paraventricular organ into the surrounding basal hypothalamus may be
the origin of some of the dopamine and 5-hydroxytryptamine containing
terminals in the median eminence (Oksche, 1983).
Although there is as yet no direct evidence of a functional link
between the systems of peptidergic and monoaminergic neurones which
innervate the hypothalamus, their overlapping distributions and the
effects of pharmacological manipulations on hormone secretion (section
1.2 and 1.3), suggest that the LHRH and putative PRF systems may be
influenced by such interactions.
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1.7. EXPERIMENTAL OBJECTIVES
Because of the large species and strain differences in factors which
influence prolactin secretion (section 1.2), the primary objective of
this study was to achieve a better understanding of the neuroendocrine
mechanisms controlling broodiness in the bantam hen. To this end the
following investigations were undertaken:
1. The anatomical distribution of 5-hydroxytryptamine-containing
neurones in the bantam brain was assessed immunohistochemically,
and the distribution of monoamine-containing neurones in the
bantam hypothalamus was assessed by a fluorescence method.
2. The functional activity of monoaminergic neurones in the
hypothalamus was compared in laying and broody bantams using a
combination of techniques based on the measurement of monoamines
by high performance liquid chromatography coupled with
electrochemical detection.
3. The distribution and changes, associated with endocrine state, of
putative 5-hydroxytryptamine and dopamine receptors in the
pituitary gland and hypothalamus of out-of-lay, laying and broody
bantam hens, were assessed by radioligand binding studies in
vitro.
4. Various pharmacological treatments were employed in vivo and in
vitro to assess the role of 5-hydroxytryptamine in the control of
prolactin secretion in the bantam hen.
5. The anatomical distribution of neurones in the bantam hypothalamus
containing vasoactive intestinal polypeptide(VIP)-like material,
was determined using an immunohistochemical technique. Further,
the possible physiological role of VIP on prolactin release was
assessed both in vivo and in vitro .
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2.0:MATERIALS AND METHODS
2.1 ANIMAL HUSBANDRY AND SURGERY
Bantam hens and cockerels were bred at the Poultry Research Centre from
a strain selected to incubate game-bird eggs at the Institute of
Terrestrial Ecology, Banchory. The birds were sexed at 24 weeks of age
and the hens were transferred to individual battery cages (46 x 30 x 40
cm), exposed to 18 hours of light per day and allowed free access to
commercial layer mash and water. The temperature in the hut was
regulated to 21°C. Only hens laying five eggs on successive days were
classified as 'laying' for experimental purposes.
Regression of the ovary and oviduct in laying hens was induced by
decreasing the photoperiod to 8 hours of light per day. After 4-6 weeks
of exposure to short days most birds had stopped laying. Those that had
stopped and whose ovary and oviduct were found to be regressed on post
mortem examination were used in studies requiring non-laying hens which
were not broody.
Incubation was induced by transferring groups of 4-6 laying hens to
deep-litter floor pens (2 x 1.5 m) containing 6 nest boxes. Hens were
allowed to accumulate clutches of eggs (6-10 eggs per bird). The
temperature in the pens was regulated to 21 °C and the photoperiod was
18L:6D. Hens that had been sitting continuously on eggs for 7—14 days
were classified as 'incubating'.
Nest-deprived—incubating (NDI) hens were used in some studies. Two
procedures were used for nest deprivation; incubating hens were removed
from their nest-boxes and allowed to remain in the pens, the nest-boxes
being sealed with heavy card. Alternatively, incubating birds were
removed from their nests and transferred to individual wire battery
cages.
Surgical ovariectomies were carried out under general anaesthesia
(Equithesin) at about 12 weeks of age while the hens were still sexually
immature. The ovary was removed through an incision between the last
two ribs, and the surrounding tissue destroyed by cautery. The site of
the contra-lateral gonad was also cauterized to prevent the development
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of an ovotestis. Ovariectomized birds were housed in cages and exposed
to an 18L:6D photoperiod until they reached somatic maturity. Birds
showing comb growth, which indicated ovarian development, were culled.
2.2 BRAIN DISSECTIONS
Birds were usually killed by cervical dislocation and decapitated. The
lower mandible and associated musculature was removed followed by the
upper mandible forward of the frontal process. This allowed the optic
nerves to be cut and the eyes to be removed. The entire ventral aspect
of the cranium was exposed by removing the musculature attached to the
basisphenoid, the presphenoid of the sphenoidal bone and the pterygoidal
bone. The ventral surface of the brain was exposed by careful removal
of the covering bone. Particular care was taken when removing the bone
surrounding the sella tu ca to ensure the pituitary gland was not
damaged.
For histological studies the whole brain was removed from the skull.
Further dissection took place in a glass petri dish on ice and consisted
of the excision of parts of the mid and hind-brain to give manageable
'blocks' for processing (usually 5-8 mm cubes).
For other studies the pitutary gland was carefully removed and
neurohypophysis cut away from the median eminence. The optic chiasma
was then removed, care being taken not to damage the median eminence.
The hypothalamus, including the median eminence, was removed as one
piece by two cuts parallel with the midline (2.0 - 2.5 mm lateral) a
transverse cut at the level of the pre-optic recess, a transverse cut at
the posterior margin of the median eminence, and a final cut parallel
with the ventral surface of the hypothalamus at a depth of 4.0 - 5.0 mm.
When necessary, the hypothalamus was further divided into anterior and
posterior portions by a transverse cut midway through the supraoptic
decussation.
The full dissection was completed within 5 minutes of death. Pituitary
glands, anterior hypothalami and posterior hypothalami destined for
neurotransmitter binding site studies and monoamine determination, were
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immediately frozen in liquid nitrogen in individual sealed tubes
(Sarstedt Ltd) and stored at -80°C for no more than 20 days before use.
The pituitary glands and posterior hypothalami for use in in vitro
incubations were stored on ice in incubation medium for no more than 30
minutes prior to use.
2.3 HISTOLOGY
An immunohistochemical technique (modified from Hsu et al. 1981) was
used to locate and map the distributions of 5-hydroxytryptamine and a
vasoactive intestinal polypeptide - like substance in brain tissue. The
distribution of the biogenic monoamines was also examined using the
sucrose-phosphate-glyoxylic acid induced fluorescence method of De La
Torre and Surgeon (1976)
2.3.1 Tissue Preparation for Immunohistochemistry
The birds were deeply anaesthetized with Sagatal (May and Baker Ltd) and
the carotid arteries were cannulated in the direction of the head.
Approximately 4 mis of heparinized 0.75% saline (1000 I.U. per ml, Boots
the Chemist) was infused through the cannuli shortly before both jugular
veins were severed. The head was then perfused under pressure with
approximately 200 mis of 0.75% saline to clear the perfusion 'loop' of
blood. This was followed by 200-300 mis of Bouin's solution without
acetic acid. The perfusion was considered to be complete when the
wattles and comb assumed the deep yellow colour of the fixative. The
brain was then removed as described earlier (section 2.2) and selected
areas excised and fixed for a further 1-4 hours in Bouin's solution.
Some blocks of brain tissue were cut on a Vibratome (Oxford Instruments
Ltd) without further processing and the sections (15-25 urn) were
immediately subjected to the immunohistochemical procedure. Most
tissues were dehydrated through a graded series of alcohols (4 x 30
minutes in 70, 90, 95 and 100% ethanol), and then exposed to several
changes of xylene until cleared.
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Wax embedding was preceded by four 30 minute incubations in liquefied
paraffin wax (60°C, Histo-Lab Ltd). The resulting blocks were trimmed
and mounted on microtome chucks and stored at 4°C.
Serial sections of 5-10)im , thickness were cut from the wax embedded
tissue on a bench-top microtome (model AO 820, American Optical Corp.).
Selected sections were floated in a water bath at 58°C and mounted on
cleaned glass microscope slides coated with a chrome alum/gelatin
mixture. Mounted preparations were dried for 18-24 hours at 30°C and
stored at 4°C until processed.
2.3.2 Immunohistochemical Procedure
The immunological steps used in the localisation of a tissue antigen can






The primary antibody (1) - antigen complex is bound by a second antibody
(2).This second antibody is an immunoglobin which has had the vitamin
biotin, chemically incorporated into it. The bound biotin moieties are
then recognised and bound by the glycoprotein avidin, which is added in
a complex with horseradish peroxidase (3). The tertiary complex thus
formed is made visible, for light microscopy, by incubation in a
L
peroxide substrate solution (in this case, diaminobenzid^ne) in the
presence of HaO2 which produces a stable coloured product.
- 37 -
The procedure used was modified from that of Sternberger et al. (1970)
and was applied to both mounted and free floating sections. Two buffers
were used in the following procedure; PBS: 50 mM phosphate buffered 0.9%
saline, titrated with 0.2 N NaoH to pH 7.4 at 4°C, and Tris-HCl.: 50 mM
Tris titrated with IN HC1 to pH 7.6 at room temperature.
1. Dewax in xylene followed by absolute ethanol.
2. 30 minutes in 0.5% ^ 0j in absolute methanol to remove endogenous
peroxidase.
3. Hydration through a graded series of alcohols followed by washing
in PBS at 4°C.
4. 10 minutes in 0.4% Triton-X-100 (Koch-Light Laboratories Ltd)
in PBS at 4°C to facilitate antibody penetration.
5. Wash in PBS at 4°C.
6. 30 minutes in 20% normal goat serum (Scottish Antibody Production
Unit, SAPU),in PBS at 4°C, to reduce non-specific background
staining.
7. 18-24 hours in appropriately diluted primary antibody (raised in
rabbit) in PBS at 4°C.
8. Wash in PBS at 4°C.
9. 30 minutes in biotinylated rabbit immunoglobin-G (Vector
Laboratories Ltd), 1:400 in PBS at 4°C.
10. Wash in PBS at 4°C.
11. 60 minutes in avidin—horse radish peroxidase complex (Vector
Laboratories Ltd), 1:250 in PBS at 4°C.
12. Wash in PBS at 4°C.
13. Wash in Tris-HCl at room temperature.
14. 2-5 minutes in 0.05% diaminobenzid^ne plus 0.003% H>02 in
Tris-HCl at room temperature.
15. Rinse in tap water and either immediately mounted with
glycerol/PBS solution, or dehydrated and mounted with DPX (BDH
Ltd).
Steps 1-3 applied only to wax embedded preparations. Sections were
processed in groups of 24 or 48. Each group contained control sections
that were incubated with normal rabbit serum (SAPU) in the place of
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primary antibody or were incubated with primary antibody which had been
exposed to the putative antigen in solution for 24 hours at 4°C. No
specific reaction product was found in control preparations.
2.3.3 Primary Antisera
The antiserum raised against 5-hydroxytryptamine (code no. 40122) was
purchased from Immunonuclear Corporation, USA. It was produced in a
rabbit against a 5-hydroxytryptamine-bovine serum albumin conjugate, and
had been shown to localise specifically 5HT in known 5HT pathways and
cell bodies in monkey, cat and rat brain. In the present study
preincubation of the diluted antiserum with 200 mg ml ^
5-hydroxytryptamine.HC1 resulted in complete inhibition of staining.
The antiserum was used at dilutions of between 1:200 and 1:1000 in PBS.
The antiserum raised against porcine vasoactive intestinal polypeptide
(pVIP) was purchased from R.I.A.(UK) Ltd. It was raised in rabbit
a
against pVIP conjugated to keyhole limpet haemocyanin-glut^raldehyde.
Preincubation of the diluted antiserum with 2 y.g ml pVIP (Cambridge
Research Biochemicals) resulted in complete inhibition of staining. The
anti-VIP serum was used at dilutions of between 1:500 and 1:2000 in PBS.
2.3.4. Localisation of Staining
Precise anatomical identification of the sites of immunohistochemical
staining was assisted by counter-staining with gallocyanin or crysol
fast violet (Bancroft and Stevens, 1982). Observed specific staining
was catalogued and plotted on transverse and para-sagittal
representations of the chicken brain (van Tienhoven and Juhasz, 1962;
Sterling and Sharp, 1982).
2.3.5 Monoamine Histochemistry
Appropriately dissected blocks of fresh brain tissue were embedded in
cryostat embedding medium (Tissue-Tek II, Tissue-Tek Ltd). After
equilibration in the cryostat cabinet (-20°C), serial sections of 20-30
jim thickness were cut and mounted on clean glass microscope slides.
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Monoaminergic fluorescence was induced using the sucrose-phosphate-
glyoxylic acid method of De La Torre and Surgeon (1976). Preparations
were examined and photographed on a Zeiss-photomicroscope II with a
fluorescent attachment. Specific reaction product was mapped on
para-sagittal representations of the chicken brain after counterstaining
with crysol fast violet.
2.4 ESTIMATION OF MONOAMINE CONCENTRATION AND TURNOVER IN BRAIN TISSUE
Monoamine neurotransmitter turnover is a dynamic equilibrium between
synthesis, storage, release and metabolism. Turnover can therefore be
assessed experimentally as a ratio between the parent monoamine and its
major metabolite,using single point estimates. Alternatively the
catabolism of the monoamine can be reduced by inhibitors of monoamine
oxidase, and the resulting accumulation of monoamine in the tissue over
time reflects the rate at which it is being produced, and by implication
reflects the functional state of that aminergic neurone (see section
1.4)
Concentrations of the biogenic monoamines in samples of brain tissue
were measured using high performance liquid chromatography (HPLC) with
electrochemical detection. The method involves the separation of the
constituents of the extracted sample by reverse-phase ion-pairing liquid
chromatography prior to their oxidation at a glassy-carbon electrode.
Differential column retention of noradrenaline (NE), adrenaline (A),
dopamine (DA), 5-hydroxytryptamine (5-HT) and their major metabolites
allowed their measurement in a single sample without elaborate
extraction procedures.
Two groups of birds were used in each experiment. One was injected with
1 ml kg ^ 0.75% saline (i.p.) and the other with 75 mg kg 1 pargyline
(Sigma) in 0.75% saline (i.p.). Pargyline is a reasonably specific
monoamine oxidase inhibitor and blocks the major pathway of
intraneuronal catabolism. In a pilot experiment (see section, 4.3.3)
the accumulation of NE, A, DA and 5HT was found to be linear over the
2.25 hour following an injection of pargyline, and appeared to be
optimal at 2 hours. Both groups of birds were killed 2 hours after
- 40 -
injection on the basis of the results of the pilot study. The
hypothalami were rapidly excised (see section 2.2) and stored at -80°C
until processed.
2.4.1 Tissue Preparation
Weighed anterior and posterior hypothalami were prepared for assay by
sonication (10 seconds, 10 microns peak to peak) on ice in 150 jil of 0.3
M perchloric acid. Following centrifugation (10,000 xg for 5 minutes)
the supernatants were collected and 20 ^1 aliquots analysed.
2.4.2 HPLC Instrumentation
The chromatograph used in all determinations comprised a Gilson 302
pumping unit and a 20 injection head above an Altex ultrasphere-ODS
ion-pairing chromatographic column (250 x 4.6 mm, 5 mm) coupled to an
LC—17 glassy-carbon transducer governed by an LC-45 electronic
controller (Bioanalytical Systems Inc.). The detector was run at 800 mV
and had a sensitivity of 2nA full scale deflection. The flow rate was
1.6 ml min generating a pressure of 3000 p.s.i.Each run lasted
between 18 and 22 minutes.
2.4.3 Mobile Phases
The mobile phases were essentially the same as those described by Mayer
and Shoup (1983):- Acetonitrile (Rathburn Chemicals Ltd) at a final
concentration of 3.5% was added to ultrapure water containing 150 mM
monochloroacetic acid, 120 mM sodium hydroxide, 1 )iM 1-octanesulphonic
acid and 0.6 jiM Naa EDTA (all chemicals were 'HPLC' grade supplied by
Fisons Ltd). After filtering through a 0.2 pm pore membrane (Millipore
Inc) and degassing, the mobile phases were completed by the addition of
sufficient tetrahydrofuran (Rathburn Chemicals Ltd) to make a 1.825%
(v/v) solution. After a further brief degassing the solution was capped
at all times to prevent evaporation of the organic phases.
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2.4.4 Standards
Noradrenaline hydrochloride, adrenaline hydrochloride, dopamine,
homovanilic acid, 5-hydroxytryptamine, 5-hydroxyindole-3-acetic acid,
3,4-dihydroxyphenyl acetic acid, 5-hydroxyhyptophan and
4-methoxy-3-hydroxyphenyl glycol as the hemipiperazine salt, were
obtained from the Sigma Chemical Company and were used as received. A
standard solution containing 1000 pmols per ml of each solute (as a
mixture) was made up in 0.3 M perchloric acid and 20 jul of this
solution was used to calibrate the HPLC system. The result of a typical
calibration run is given below.
RUNTIME CM INS)
2.4.5 Data Handling
Chromatographs resulting from injection of samples of unknown
composition were analysed by calculation of peak area and retention time
relative to a calibration run of known concentration by a Gilson
'Datamaster' data reduction unit, and were corrected for original wet
weight of tissue.
Steady state estimations of all monoamines were calculated as the mean
and standard error of the mean, in groups of 8 birds killed two hours
after injection with saline. The difference between the steady state
estimate and that from groups of 8 birds killed two hours after
injection with pargyline, was the turnover index.
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2.5 RADIOLIGAND BINDING STUDIES
The binding of 3 H-lysergic acid diethylamide to putative
5-hydroxytryptamine receptors and3 H-domperidone to putative dopamine
receptors in preparations of hypothalami and pituitary glands was
assessed in vitro.
2.5.1 Tissue Preparations
Brain tissue from non-laying , laying, incubating and p-chloramphetamine
treated (see section 2.6.3) bantam hens was collected and stored as
described in section 2.2, and processed in one of the following ways;-
1. It was homogenized in 10-20 volumes of ice-cold 0.32 M sucrose,
followed by centrifugation (4°C) at 1000 x g for 10 minutes to
yield the crude nuclear pellet (PI). The crude mitochondrial
pellet (P2) was then isolated from the supernatant by
centrifugation (4°C) at 20,000 x g for 10 minutes. The P2
was lysed by homogenization in 10-15 volumes of ice-cold Hz 0
and centrifuged at 8000 x g for 30 minutes. The supernatant
and soft upper 'buffy coat' of the residual P2 pellet (RP2) were
collected and centrifuged (4°C) at 100,000 x g for 20 minutes to
yield the crude synaptic membrane pellet (CSM). PI, RP2 and CSM
pellets were superficially washed with water and resuspended in
the appropriate incubation buffer by gentle homogenisation.
2. It was disrupted in 20-50 volumes of ice-cold buffer A (see
below). using a polytron (setting 5 for 20-30 seconds). Total
particulate material was isolated by centrifugation (4°C) at
50,000 x g for 30 minutes. The pellet was washed twice in
buffer A by rehomogenisation and centrifugation. Between
washes the homogenate was incubated for 10-15 minutes at 30°C.
After the second wash the pellet was resuspended in the
appropriate incubation buffer (B or C).
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The buffers used were the following;
Buffer A : 50mM Tris-HCl pH 7.4 at 4°C
Buffer B (for 3H-LSD studies): 50mM Tris-HCl containing 2.7 mM
CaCl2 , 9pM pargyline and 0.1% (w/v) ascorbic acid. The
final pH was adjusted to 7.4 at 40°C with IN HC1.
Buffer C (for 3H-domperidone studies): 50 mM Tris-HCl containing
120 mM NaCl, 5 mM KC1, 2 mM CaCl2 , 1 mM MgCl2 , 10 JiM
pargyline and 0.1% (w/v) ascorbic acid. The final pH
was adjusted to 7.4 at 37°C with IN HC1.
All buffers were prepared immediately prior to use in clean glassware
using ultrapure water (Millipore MX water purifying unit)
2.5.2 Binding Experiments
Preliminary experiments were performed to ascertain the degree of
specific binding to various tissue fractions, to establish the
relationship between binding capacity and tissue/protein concentration,
and to optimise incubation time and temperature. These experiments were
performed for both radio-ligands using homogenised whole hypothalami
from laying hens.
Using the preliminary data to define the assay conditions two types of
binding experiment were routinely performed:
1. Saturation studies in which known concentrations of radioligand in
the nano-molar range were incubated in triplicate with a fixed
concentration of prepared tissue. The non-specific binding
component at each concentration of radioligand was also
determined in triplicate in a parallel incubation in the
presence of an excess of the unlabelled ligand.
2. Displacement studies in which the specific binding of a single
known concentration of radioligand (close to the estimated K^) to
a fixed amount of tissue, and the ability of an unlabelled test
ligand to inhibit this binding, was determined.
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2.5.3 3H-LSD Binding Protocol
The experimental protocol for3 H-LSD binding studies (modified from Pert
and Snyder, 1973) required the estimation of total binding (TB),
non-specific binding (NSB), and displacement of total binding by test
ligands (DTB). All estimates were made in triplicate and carried out in
clean glass tubes (9 x 60 mm) containing the following;
Total binding: IOOjjI of 3 H-LSD, lOOpl of Buffer (B) + 500 ^pl of
tissue homogenate.
Non-specific binding: 100 jal of 3 H-LSD + 100 jil of 0.7 jjM LSD +
500 ^il of tissue homogenate.
Displaced total binding: 100 yl of 24 nM 3 H-LSD + 100 jil of test
ligand + 500 jal of tissue homogenate.
For saturation studies, both TB and NSB were estimated for each
concentration of 3 H-LSD used. For displacement studies 3 H-LSD at a
final concentration of 4nM was used while the concentration of test
ligand was altered.
(N-methyl-3H) lysergic acid diethylamide was purchased from New England
Nuclear (W Germany) and had a specific activity of between 50 and 60 Ci
mmol depending on batch. Lysergic acid diethylamide as the tartrate
salt (LSD) was purchased from Sandoz Pharmaceuticals Ltd (London). Test
ligands used were LSD, quipazine (Miles-Davis Ltd), cyproheptadine
(Janssen Phamaceuticals Ltd), 5-hydroxytryptamine and dopamine (both
Sigma). Test ligands were dissolved in buffer B. Quipazine and
cyproheptadine were initally dissolved in acidified H2O.
Ice-cold tissue homogenate was added to previously prepared tubes
containing the appropriate reagents at 4°C. The contents were mixed on
a rotamixer and placed in a shaking water bath at 40°C. The incubations
were terminated after 30 minutes by the addition of 5 ml of ice-cold
buffer A^and rapid filtration. Glass fibre filters of 16 Jim pore size
(GFA, ^atman Ltd), soaked for 10-24 hours in 0.1 jM LSD, were used in a
vacuum filtration manifold (VFM3, Amicon Ltd). Following filtration,
the samples were washed with 4 x 10 mis of ice-cold buffer A (10-15
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seconds). The filters were air dried for 1-2 hours at room temperature
and then placed in scintillation vials containing 1 ml of protein
digestant (Protosol, New England Nuclear Ltd). The capped vials were
left at room temperature overnight before neutralisation with 50 pi of
glacial acetic acid. After the addition of 10 ml of scintillation
cocktail (Fisoflour 1 MPC, Fisons Ltd), and several hours of
equilibration in the dark, the samples were counted on a Beckmann LS-230
p-counter.
2.5.4 3H-Domperidone binding Protocol
A similar procedure was used to assess 3H-domperidone binding (modified
from Baudry et al. 1979). All estimates were made in triplicate and
carried out in clean glass tubes (9 x 60 mm) containing:
Total Binding (TB): lOOpl 3H-domperidone + 100 pi buffer C + 200
V1 tissue homogenate.
Non-Specific Binding (NSB): 100 pi of 3H-domperidone + 100 pi of
4 pM domperidone + 200 pi tissue
homogenate.
Displaced Total Binding (DTB): lOOul of 16 nM 3H-domperidone +
100 pi test ligand + 200 pi tissue homogenate.
For saturation studies TB and NSB were estimated for each concentration
of 3H-domperidone. A final concentration of 4 nM 3H-domperidone was
used in all tubes for displacement studies while the concentration of
test ligand was altered.
(Benzene ring-3H)-domperidone was purchased from New England Nuclear(W.
Germany) and had a specific activity of between 30 and 35 Ci mmol ^ .
Domperidone was the kind gift of Janssen pharmaceuticals Ltd. Test
ligands used were domperidone, (+) butaclamol (Research Biochemicals
Inc. USA) (-) butaclamol (Ayrst pharmaceuticals Ltd) apomorphine,
5-hydroxytryptamine, dopamine (all from Sigma Ltd.) and methysergide
(Sandoz Products Ltd). Domperidone, butaclamol and apomorphine were
dissolved in 0.7% lactic acid prior to dilution in buffer C.
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The incubations lasted 30 minutes and were maintained at 37°C in a
shaking water bath. They were terminated by the addition of 5 ml of
ice-cold buffer A and rapid filtration followed by 3 x 5 ml washes with
ice-cold buffer A. Samples were prepared as before for ^-counting. The
filters were pre-soaked in 1 ^iM domperidone for 16-24 hours prior to
use.
2.5.5 Blanks
Experimental blanks were included in all binding studies. These took
the form of tubes in which the homogenate was replaced with buffer. The
binding of radioligands to the filters was less than 1% of total bound
activity. Counting efficiency was periodically calculated by the
addition of a known amount of 3 H-Hexadecane to a previously counted
sample.
2.5.6 Protein Determinations
Protein concentrations in tissue homogenates were determined by a
modification of the Coomassie Brilliant Blue method (Bradford, 1976).
Rabbit gamma-globulin (Sigma) was used as the protein standard over a
range of 1-25 yg ml Concentrated Coomassie Brilliant Blue G-250 dye
reagent (0.2 mis, Bio-Rad Labs Ltd) was mixed with 0.8 mis of standards
and appropriately diluted samples in clean glass test tubes. Reagent
'blanks* contained 0.8 mis of the appropriate buffer. After 15-30
minutes the optical density at 395 nm was measured on an SP500
spectrophotometer (Pye-Unicaw). Unknown sample potencies were calculated
using the equation derived from linear regression of the optical density
versus concentration of standards.
2.5.7 Calculation of Specific Binding
After the subtraction of 'blank' values from the raw data, the values
for specifically bound counts were calculated by the subtraction of the
means of triplicate estimates of total binding and non-specific binding.
The value for specifically bound counts was converted to concentration
of ligand specifically bound per unit protein in the following manner;
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B = x x — x —
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Where B is bound ligand (fmol) per milligram protein, CPMSP is the
estimate of specific counts bound, E is the percentage efficiency of the
counter, SA is the specific activity of the radioligand (Bq f mol ) and
P is the amount of protein present in the incubation in milligrams.
2.5.8 Scatchard and Hill Analysis
Throughout these studies the maximum tissue binding of radioligand
represented less than 8% of the total amount of radioligand added to the
incubation. Loss of up to 10% of the radioligand from the incubation
system through tissue binding has been shown to have no significant
effect on estimates of binding constants, when the added concentration
of radioligand is taken as equal to the actual free ligand at
equilibrium (Wells et al. 1980; De Lean et al. 1981). For the present
purposes the concentration of free radioligand at equilibrium was taken
as equal to the concentration of radioligand added.
Linear regression by the method of least squares was performed to give
the line of best fit for a plot of bound/free versus bound radioligand.
The slope of this line is equal to the negative reciprocal of the
equilibrium binding constant (Kp), and its abscissa intercept is equal
to the apparent maximum number of binding sites (Bmax).
This follows from the Scatchard equation (Scatchard, 1949) which can be
represented as:
B B max -B
F ^
From a plot of log10 (B/Bmax -B) versus log^Free the Hill binding
constant (K^) an alternative estimate of Kp, is the abscissa value where
Log 10 (B/Bmax -B) equals 0. The slope of the line of best fit
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calculated by linear regression gave the Hill number (Hn) which is a
measure of binding homogeneity. /The Hn is unity, provided there is no
cooperativity, there is a single homogeneous class of binding sites and
the law of mass action is obeyed (Koshland, 1975). The Hn is calculated
from the following equation;
B
log = n log (L) - log
(Bmax—B)
where n is the theoretical number of ligand binding sites per receptor
molecule, is a composite constant of the and interaction factors
that determine the degree to which is altered by each discrete
binding step, and (L) is the concentration of radioligand.
In analysis of data from displacement studies, the difference between
total CPM bound in the presence of test ligand and non-specific CPM
bound, expressed as a percentage of specific CPM bound, allowed the
construction of displacement curves. The data was also plotted as log
%B max/(100-%Bmax) versus log (D) in a modification of the Hill plot,
where (D) is the concentration of test ligand.
All data analysis was performed by computer using the Minitab data
processing package.
2.6 PHARMACOLOGICAL TREATMENTS IN VIVO
Various drugs were tested for their ability to influence prolactin and
luteinizing hormone secretion in laying and broody bantam hens. Most of
the studies were short-term and all involved blood sampling by
venepuncture prior to and at intervals following drug administration.
Plasma samples were stored at -20°C until assayed for prolactin content
in homologous and /or heterologous radioimmunoassays and for luteinizing
hormone in a homologous radioimmunoassay.
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2.6.1 Manipulation of 5-Hydroxytryptamine Function
The following drugs and some combinations thereof were all injected
intraperitoneally, while a control group received an injection of
vehicle;

























2.6.2 Vasoactive Intestinal Polypeptide.
The influence of porcine vasoactive intestinal polypeptide (pVIP
Cambridge Research Biochemicals) on prolactin, luteinizing hormone and
growth hormone secretion was examined. Blood samples were taken prior
to and at intervals after intra-venous injection of pVIP or saline.
Plasma samples were stored at -20°C until assayed for prolactin,
luteinizing hormone and growth hormone by radioimmunoassay. Growth
hormone determinations were performed by Dr. S. Harvey of the Wolfson
Institute, University of Hull.
2.6.3 p-Chloramphetamine Treatment
The selective 5-hydroxytryptamine neurotoxin ,p-chloramphetamine (Sigma)
was administered to laying birds (20 mg kg in 0.75% saline, i.p.)
every second day for 13 days.Another group of birds was injected with
an equivalent volume of saline on the same schedule. Groups of treated
and control birds were killed on day 14 and day 21. The hypothalamic
content of monoamines in these birds was measured by HPLC with
electrochemical detection to assess the efficacy of the treatment. Most
of the birds were killed by cervical dislocation on day 22 and their
hypothalami were taken for a series of 3H-LSD binding studies.
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2.7 PHARMACOLOGICAL MANIPULATIONS IN VITRO
The effect of vasoactive intestinal polypeptide and the 5HT receptor
agonist quipazine on prolactin release from the pituitary gland, was
assessed using an in vitro incubation system modified from Border and
Chadwick (1977) and Harvey et al. (1979). Aliquots of the resulting
incubate were measured for prolactin content by radioimmunoassay and
also analysed by polyacrylamide gel electrophoresis.
2.7.1 Tissue Collection
Anterior pituitary glands and posterior hypothalami were rapidly removed
from birds killed by cervical dislocation. They were stored on ice in
incubation medium for up to 30 minutes. The glands were then bisected
longitudinally and the blotted halves weighed.
2.7.2 Incubations
Hemipituitary glands and posterior hypothalami alone and together were
incubated in 200 ul of normal medium or medium containing the test drug.
The incubations were performed in medium 199 with Earle's salts and
sodium bicarbonate (0.22%) (Flow laboratories, Ltd) containing lmg ml 1
-1 -1
glutamine, 0.1 mg ml penicillin, 0.05 mg ml streptomycin, at 39°C
over 4 hours and were continuously gassed with a 95% C02/5% O2 mixture.
After incubation the tubes were placed on ice, the medium rapidly
aspirated and stored at -20°C until assayed. Porcine vasoactive
intestinal polypetide (Cambridge Research Biochemicals) and quipazine
were dissolved in incubation medium on the day of the experiments and
_7
were used at a concentration of 10 mole/1.
2.8 POLYACRYLAMIDE GEL ELECTROPHORESIS
Various protein constituents of post-incubation media and aqueous
extracts of anterior pituitary glands and neurohypophyses were separated
by non-dissociating discontinuous polyacrylamide gel electrophoresis
(modified from Hames, 1981).
2.8.1 Reagents
The following stock solutions were prepared in clean glassware using
ultrapure water and 'electrophoresis' grade chemicals (Fisons Ltd).
A. Resolving gel buffer: pH 8.9, 36.3 g Tris + 48 mis 1M HC1 in 100
ml H^O.
B. Stacking gel buffer: pH 6.9, 6.0 g Tris titrated with 1M HC1 in
100 ml H20
C. Acrylamide-bisacrylamide: 28 g acrylamide + 0.7 g N,N',-methylene
bisacrylamide in 100 ml H20
D. Acrylamide-bisacrylamide: 10 g acrylamide + 2.5 g N,N',-methylene
bisacrylamide in 100 ml H20
E. Sucrose solution: 40 g sucrose in 100 ml H20
F. Persulphate solution: 0.28 g ammonium persulphate in 100 ml H20
G. Running buffer: (pH 8.3) 14.lg glycine + 3.0 g Tris in 5000 ml
h2O
H. Staining solution: 0.1% Coomassie Brilliant blue R250 in a 5:5:2
mixture of H20: methanol: glacial acetic acid
I. Destaining solution: 30% methanol + 10% acetic acid in H20
2.8.2 Gel Preparation
Slab gels, equivalent in nature to those used in a prolactin assay based
on tube gel electrophoresis (see Nicoll and Nichols, 1971), were
prepared. Low porosity (7.5%) resolving gel was made by mixing part for
part; lxA, 2xC, 1 x H2O, 4xF and 2.3 pi of
tetramethylethylenediamine (TEMED, Fisons Ltd) per ml of A. High
porosity (3.5%) stacking gel was made by mixing, IxB, 2xD, 3xE, 2
x F and 5 pi of TEMED per ml of B. Both mixtures were kept on ice until
the gels were cast.
Using a 16 x 14 cm slab gel casting stand (Bio-Rad Labs Ltd), the
resolving gel (14 x 12 x 0.3 cm) was overlayed by a stacking gel (14 x 4
x 0.3 cm). Sample wells of 200 pi volume were created in the stacking
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gel by a 20 tooth teflon comb. Each sample (25 jil) was mixed with 175
;il of stacking gel containing 0.002% Bromophenol Blue and layered into
individual sample wells.
2.8.3 Electrophoretic Conditions
The completed gels were placed in a water cooled slab gel cell (Protean,
Bio-Rad Labs Ltd). Samples were stacked at a constant current of 20 mA
supplied by an LKB 2103 power supply. Once the proteins had migrated
into the resolving gel the system was run at a constant current of 50 mA
until the ion front, marked by the tracking dye, migrated 10 cm towards
the anode.
2.8.4 Post-electrophoretic Processing
When electrophoresis was completed, the gels were rapidly removed from
the tank and either immersed in staining solution (H) for 16 hours at
room temperature, or selected 'tracks' were cut from the body of the gel
and divided into 0.5 cm sections from the ion front to the origin.
Protein bands were differentiated in the stained gels by repeated
immersion in destaining fluid (I). The sections of cut gel were
homogenised in 1 ml of 0.5 mM phosphate buffered saline (pH 7.4) and
left at 4°C for 48 hours to allow the protein to elute. After
centrifugation (4°C, 1000 xg) the supernatant from each gel segment was
assayed for prolactin content in the homologous radioimmunoassay.
Stained gels were photographed and the negatives analysed by
densitometry using a scanning densitometer (DD2,Kipp and Zonen Ltd).
Micrograph records of densitometric scans were analysed using a M0P/AM02
digitiser (Kontron, FGR) linked to a Primos computer package (created by
Dr J Filshie of the PRC) for band RF values and peak area.
2.9 HORMONE DETERMINATIONS
Prolactin and luteinizing hormone radioimmunoassays, performed on plasma
and samples from in vitro studies, were of the double antibody
post-precipitation type and shared a similar protocol. Growth hormone
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determinations were performed by Dr S Harvey the Wolfson Institute
(University of Hull) using a homologous chicken growth hormone
radioimmunoassay (Harvey and Scanes, 1975).
2.9.1 General Assay Protocol
125
1. Total counts (x3); tubes containing I-hormone only
2. Blanks (x3); tubes containing all reagents except first antibody
and hormone
3. Zero standard(x6);tubes containing all reagents except unlabelled
hormone
4. Standards (x3); tubes containing all reagent and known
concentrations of hormone
5. Control sample (x3); tubes containing all reagents and the
relevant plasma pool at various dilutions
6. Unknown samples (x2); tubes containing all reagents plus
appropriately diluted experimental samples
2.9.2 Assay Procedure
Day 1. Standards and unknown samples were diluted and dispensed
into assay tubes.Diluent was added at the appropriate volume
to'Blank' and 'Zero Standard' tubes.First antibody was added
to all tubes except 'total counts' and 'blanks'.The contents
were mixed using a rotamixer and incubated at 4°C for 24
hours.
125
Day 2. I-hormone was added to all tubes, contents were mixed
and incubated for 24 hours at 4°C.
Day 3. Second antibody (precipitating serum) was added to all
tubes.The contents were mixed and incubated at 4°C for a
further 24-48 hours
Day 4. All tubes except 'total counts' were centrifuged (4°C) at
1500 xg for 40 minutes. Starch solution (50 jil of 5% w/v)
was added to all tubes and they were spun for a further 10
minutes. The supernatant was then removed by a suction
pipette.
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All tubes were counted for 100 seconds on a Wallac 80,000 Gamma Sample
Counter (LKB Ltd).
All samples and reagents were dispensed using a Microlab M diluting
dispenser (Hamilton Ltd) into disposable polystyrene tubes (30 x 6 mm).
Assay diluent was 0.04 M Naj P0^ containing 0.15 M NaCl, 8 mM EDTA, 2%
normal horse serum and 0.1% (w/v) NaN3 . 1M NaOH was used to titrate the
diluent to the required pH.
2.9.3. Assay Parameters
RIA: Homologous Prolactin Heterologous Prolactin Homologous LH
Key Ref;
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'Bound' to 'Free' ratios were calculated by comparing the counts in
'blank' and 'zero standard' tubes. The amount of labelled hormone bound
to the antibody in the absence of unlabelled hormone represented 100%
binding. The amount of labelled hormone bound decreases as the amount
of unlabelled hormone is increased forming a sigmoid curve. The
standard curve was linearised using logit-log transformations and
iterative least squares regression analysis. Unknown sample potency
estimates and 95% confidence limits were based on the pooled residual
variance of the standard curve and sample and calculated using a
computer programme (Robard and Lewald, 1970).
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3.0: THE ANATOMICAL BASIS OF THE PUTATIVE MONOAMINERGIC CONTROL OF
ANTERIOR PITUITARY GLAND FUNCTION.
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The original mapping of monoamine-containing neurone systems in the
mammalian (Fuxe, 1965; Pin et al, 1968) and avian brain (Fuxe and
Ljunggren, 1965; Sharp and Follett, 1968; Ikeda and Gotoh, 1971) made
use of a formaldehyde-induced fluorescence (FIF) technique developed by
Dahlstrom and Fuxe (1964). Modifications to the FIF technique (eg Bloom
and Battenberg, 1976; Ajelis et al. 1979; Maeda et al. 1979), and their
application to fresh frozen tissue (eg: Loren et al. 1980), have vastly
improved the detection of catecholamines in brain tissue. Unfortunately
the FIF and other histofluorescent methods have a low sensitivity
towards 5-hydroxytryptamine (5HT), and the yellow fluorescent product
formed (B-carboline) is highly sensitive to ultra-violet irradiation
resulting in rapid fading of the fluorescence (Schofield and Wreford,
1979).
Alternative methods used to study central 5-HT containing neurones
include autoradiography of radiolabelled 5HT taken up into the brain
after intracisternal injection (Calas et al. 1974; Chan-Palay,
1977,1982) and immunohistochemical localisation of tryptophan hyroxylase
and DOPA-decarboxylase (Hokfelt et al. 1973; Joh et al. 1975; Pickel et
al. 1977). More recently direct localisation of 5-HT has been achieved
by immunofluorescent techniques (Steinbusch and Nieuwenhuys 1981, 1983;
Steinbusch, 1981; Howe et al. 1983) and peroxidase-antiperoxidase based
immunohistochemistry (Steinbusch et al. 1982 a,b; Kojima et al. 1983)
using antibodies raised in rabbit against 5HT conjugated to bovine serum
albumin.
In the present study,the sucrose-phosphate-glyoxylic acid method was
used to localise catecholaminergic neurone systems in the hypothalamus,
and the avidin-biotin based immunohistochemical technique was used to
demonstrate the 5HT-containing neurone systems in the brain.
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3.1 Distribution of 5HT—Immunoreactivity in the Hind—brain and
Hypothalamus
The perikarya of 5HT-immunoreactive neurones were mainly found in the
hind-brain. A single grouping of perikarya was also found in the
paraventricular organ of the hypothalamus. Fine fibres containing
5HT-immunoreactivity were found throughout the hypothalamus and anterior
hind brain.
3.1.1 Distribution of 5HT-Immunoreactive Perikarya
Immunoreactive perikarya occurring in the hind brain displayed regional
variations in size, number, and density of staining. Five cell
groupings were discernible in the medial hind-brain (see fig 4).
Group 1: These cells, forming the most posterior grouping observed,
appeared as weakly staining spindle shaped cells, sparsely distributed
bilaterally medial to the nucleus nervi hypoglossi.
Group 2: These perikarya were large, multipolar and strongly
immunoreactive, and were distributed within the middle portion of the
raphe nucleus. Although forming a narrow band around the midline (see
Fig 5A), they were extensively distributed rostro-caudally. The rostral
end extended to the level of the nucleus nervi facialis.
Group 3: Immunoreactive perikarya in this group were of medium size
and usually multipolar. They were widely distributed in the medial and
paramedial portions of the middle pons (fig 5B).
Group 4: These cells were small and lightly stained with a lateral
distribution in the ventral pons close to the lateral fasciculus
longitudinalis medialis (Fig 5C).
Group 5: This large group of densely packed perikarya occurred mainly
in the linea caudalis,ventral to the decussatio brachiorum
conjunctivorum of the pons (Fig 5C).
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Figure 4: 5-hydroxytryptamine (5HT) irnmunoreactivity in the bantam
brain. 5-HT was located immunohistochemically in para-sagittal
preparations of 6 brains and plotted on a representation of the brain
0.5mm lateral to the midline. Perikarya containing 5HT are denoted by
solid circles, while areas abundant in fibres and terminals containing
5HT are denoted by stipling. The £}6ups of cells, numbered 1-8, are
described in detail in the text. The letters A—J refer to the
transverse representations of the bantam brain in figure 5.
Abbreviations: AC anterior commisure, FLM fasciculus longitndinalis
medialis, LC nucl. linearis caudalis, ME median eminence, NL neural
lobe, PIT pituitary gland, POR pre-optic region, PVM nucl.
parayenticularis magnocellularis, PVO para-ventricular organ, R nucl.
raphe, VMN nucl. ventromedialis hypothalami.
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Figure 5: A-J Distribution of 5HT-immunoreactive perikarya ( •) and
fibres (+) in transverse sections through the bantam brain. The planes
of sections are shown by the arrows in figure 4. These representations
were compiled from observations of 5HT immunoreactivity detected in
transverse sections of 11 brain preparations. Abbreviations; see
appendix.
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An additional two groups (6 and 7) of weakly staining 5HT-immunoreactive
perikarya were observed in the lateral hind brain (Fig 5B and Fig 5D).
Within the hypothalamus, immunoreactive perikarya were observed in the
paraventricular organ (group 8 in Figure 4). The cells formed a laminar
structure around the third ventricle and were bipolar (Fig 5G + 5H).
One process of each cell usually projected towards the wall of the
ventricle and may be similar to the 'liquor-contacting' neurones
described by Vigh-Teichman et al (1970). The other process extended
laterally towards the infundibular nuclear complex.
This distribution of perikarya is consistent with the observations of
Yamada et al. (1984) in the young chicken.
3.1.2 5-HT Immunoreactive Fibres
Fine immunoreactive fibres and characteristically punctate terminals
occur throughout the hypothalamus and hind brain. Relatively coarse,
beaded fibres were found only in regions adjacent to immunoreactive
cells. Although apparently ubiquitous in their distribution, areas
which contained higher densities of fine, immunoreactive fibres were
discernible.
A major division of fibres originating from cells in the hind brain
occurred at the level of the oculomotor nerve (Fig 5D + 5E); one group
passed superior to the fasciculus longitudinalis medialis, passing
through the upper part of the posterior hypothalamus and spreading
throughout the pre-optic area and septal region < F i ntf") . while the
other group passed laterally round the oculomotor nerves into the basal
hypothalamus (Fig 5E), towards the lateral tuberal area. Coarse beaded
fibres emanating from the cells in the paraventricular organ passed
laterally and descended through the lateral basal hypothalamus towards
the infundibular nuclear complex (Fig 5G + 5H). Dense fibre staining
occurred in the lateral tuberal area extending downwards to the lateral
margins of the median eminence (Fig 5F + 5L + 5H). Dense fibre and
terminal staining also occurred in the anterior hypothalamus. Large
numbers of fine immunoreactive fibres were found around the region of
- 63 -
-I
the anterior commissure (Fig 5<J). The pre-optic region itself was rich
in immunoreactive fibres and terminals which were not associated with
T
particular nuclear groupings (Fig 5S). Fine terminal staining was also
found in the organosum vasculosum lamina terminalis. A few fibres with
a rostro-caudal orientation were observed above the supraoptic
decussation between the preoptic area and the basal hypothalamus (Fig 51
+ 5J)
3.2 Catecholamine Distribution in the Hypothalamus
Studies in the quail (Sharp & Follett, 1968) and chicken (Ikeda and
Gotoh, 1971; Duabe and Parent, 1981), have outlined the distribution of
catecholamine containing structures in the avian brain. A limited study
was conducted to confirm the hypothalamic distribution of the
catecholamines in the hypothalamus of the bantam hen.
When exposed to ultra-violet light after immersion in a solution
containing glyoxylic acid (de la Torre and Surgeon, 1976) cryostat
sections of fresh frozen tissue emitted yellow and green fluorescence .
The yellow fluorescence associated with 5-HT faded quickly when
examined, while the green fluorescence associated with the
catecholamines persisted. No detailed examination of the hind brain was
conducted but subjectively the monoamine perikarya observed in this
region corresponded to the groupings outlined by Ikeda and Gotoh (1971).
In the hypothalamus strong green fluorescence occurred in cells of the
paraventricular organ. Beaded fibres radiating from these cells were
observed to descend laterally towards the infundibular region. Heavy
catecholamine fluorescence occurred in the posterior tuberal area
associated with the nucleus mammilaris lateralis and the infundibular
nuclear complex. The lateral median eminence contained considerable
amounts of catecholamine fluorescence and the internal layer of the
median eminence contained fine catecholamine containing nerve fibres.
Some fibres were seen to descend from the internal to the external layer
of the anterior median eminence. The pre-optic region of the
hypothalamus also contained abundant catecholamine fibres. No
particular nuclear associations were observed in this region although
catecholamine fibres were particularly dense in the medial and ventral
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regions of the nucleus praeopticus paraventricularis magnocellularis.
The catecholaminergic innervation of the anterior hypothalamus was
similar to that observed for 5HT. Figure 7 contains photomicrographs of
the catecholamine fluorescence.
3.3 Discussion: Possible Sites at Which Monoamines May Influence
Neuroendocrine Function
The current understanding of the avian hypothalamic neurosecretory
system is based on anatomical evidence suggesting the organisation of
neurosecretory cells two distinct components. These are the
classical aldehyde-fuqsin positive magnocellular neurosecretory system
W~
and the aldehyde-fuqsin negative parvocellular or hypophysiotrophic
system (Mikami, 1980). The median eminence and neurohypophysis are the
common anatomical end points of these convergent systems. The
magnocellular neurosecretory cells are thinly dispersed throughout the
preoptic-hypothalamic transitional areas in the rostral hypothalamus and
send efferent fibres to the median eminence and neurohypophysis via the
hypothalamo—hypophyseal tract. The parvocellular cells located in the
basal and anterior hypothalamus send efferent fibres only to the median
eminence (Mikami et al. 1978)forming the tubero-hypophyseal tract.
The identification and analysis of individual neuronal systems in the
avian brain by means of histochemistry and more recently
immunohistochemistry, have demonstrated the complex heterogeneous nature
of the avian hypothalamic nuclei (Oksche, 1983).
Several neuropeptide systems have been identified immunohistochemically
in the chicken central nervous system. Both neurohormonal and/or
neurotransmitter roles have been ascribed to the various neuropeptides
on the basis of their anatomical relationship to other neurones and
neurohaemal areas in the brain (Blahser, 1983). Of the petidergic
systems known to have a neurohormonal function, the LHRH-system has
particular relevance to the endocrine changes associated with
broodiness. The distribution of the LHRH-system in the chicken brain
has been described by Sterling and Sharp (1982). The LHRH-containing
cell bodies are located in the rostral anterior hypothalamus, in front
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of the classical magnocellular neurosecretory cells,and project fibres
through the ventral hypothalamus which terminate in the median
eminence.
The similarities in anatomical location within the hypothalamus between
monoaminergic neurones and elements of the avian neuropeptidergic
system, suggest that interaction between the two systems may occur at
several levels:
1. Within the median eminence, a dense catecholaminergic innervation
was observed, and although little 5-HT immunoreactivity could be
detected , measurements of this monoamine, using HPLC with
electrochemical detection, show it to be present in high
concentrations (Talbot et al. 1984). Monoamines in the median
eminence may influence hormone secretion from the pituitary gland,
by an interaction with neuropeptidergic terminals to regulate the
release of peptide factors into the hypophyseal portal
vasculature. In addition they may also modulate the effects of
neurohormonal releasing/inhibiting factors at the level of the
target cell in the pituitary gland.
2. The activity of the hypophysiotrophic neurosecretory cells in the
basal hypothalamus may be modulated by the monoamine - containing
terminals which originate in the hind brain and the
paraventricular organ.
3. The intense innervation of the anterior hypothalamus by
monoaminergic systems may influence the activity of the
magnocellular neurosecretory cells and LHRH-containing cells.
4. Further, more complex, interactions between monoaminergic and
neurosecretory neurones may also occur if these peptide systems
are ascribed neurotransmitter/neuromodulatory roles.
The anatomical proximity of elements of the neurosecretory cells and
5-HT and catecholaminergic systems although suggestive of an
interaction, is not adequate evidence for a functional association.
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Only the presence of synaptic connections between monoaminergic and
peptidergic systems, which will require detailed immunohistochemical
investigation, at the electron microscopic level, will confirm these
possible links. However, indirect evidence of an interaction may be
found by a detailed study of the functional activity of monoaminergic
systems in various endocrine states, and the effects on hormone
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Figure 6: Photomicrographs of 5HT-immunoreactivity in the bantam brain;
A. Perikarya in the dorsal raphe nucleus
B. Perikarya in the para-ventricular organ
C. Fibres in the region of the infundibular nuclear complex
D. Fibres below the anterior commissure
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Figure 7: Photomicrographs of mono-aminergic fluorescence in the bantam
brain; A:Cells in the dorsal raphe nucleus (x40). B:Cells in the nucl.
linearis caudalis (x40). C:Cells in the PVO (x40). D:Fibres in the
region of the NOC (xlO). E. Fibres in the lateral tuberal area (xlO).
F. Fibres in the Infundibular Nuclear Complex (xlOK G. Fibres in the
INC (x40). H. Sagittal section through the median eminence (x20). I.
Sagittal section through the median eminence (x40), J. Fibres running
rostrocatldally in the region of the Supra-optic decussation (x20).
K.Fibres and terminals in the OVLT (x20). L. Fibres in the POA,
sagittal section (xlO).
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4.0: THE FUNCTIONAL ACTIVITY OF HYPOTHALAMIC MONOAMINES IN BROODINESS
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The onset of incubation in the bantam hen is characterised by an
increase in the plasma concentration of prolactin and a decrease in the
plasma concentration of luteinizing hormone (Lea et al. 1981). After
the eggs hatch, plasma levels of prolactin fall, while those of
luteinizing hormone (LH) progressively increase (Sharp et al. 1979). In
the turkey, a similar fall in plasma prolactin (El Halawani et al. 1983)
accompanied by an increase in plasma LH (EL Halawani et al. 1983) occurs
if incubation is terminated prematurely by removing the nest. Since the
secretion of LH and prolactin in turkeys and chickens is probably
controlled, at least in part, by monoamines (see section 1.2 and 1.3) it
is likely that hypothalamic monoamines are involved in the regulation of
LH and prolactin secretion in broody bantams. The abundant innervation
of the bantam hypothalamus with neurones containing 5-hydroxytryptamine
(5HT) and catecholamines .provides the anatomical basis for such a
regulatory mechanism.
The primary purpose of the following series of experiments was to
correlate the changes in the concentration and turnover of monoamine
neurotransmitters in the hypothalamus, with the changes in the secretion
of prolactin and LH associated with the development and termination of
incubation. Since incubation can be conveniently terminated by removal
of the nest ,an initial study was performed to determine the effects of
nest removal on plasma levels of prolactin and LH. It was anticipated
that the nest-deprived bantam hen would provide a convenient model for
studying changes in hypothalamic function immediately after reversing
the changes in prolactin and LH secretion which occur at the onset of
incubation.
4.1 The Effect of Nest—Deprivation on Plasma Levels of Prolactin and LH
The effect on plasma levels of prolactin and LH of depriving incubating
hens of their nests for 24 hours, is shown in figure 8. Shortly after
nest removal.prolactin levels began to fall and after 12 hours were
significantly lower than in the non-deprived control group (p < 0.01,
unpaired t-test, n=6). All the nest-deprived hens re-started incubating
within 10 minutes of being returned to their nests. Re-nesting was
accompanied by a rapid rise in plasma prolactin. Plasma levels of
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prolactin were not significantly different from those in control birds
12 hours after nest return. A similar pattern of change in plasma
levels of prolactin was detected when the same samples were assayed in
the heterologous prolactin radioimmunoassay.
Within 3 hours of nest-removal, plasma levels of LH were significantly
increased when compared with control values (p<0.01, unpaired t-test),
and remained elevated until the birds were allowed to re-nest. After
re-nesting plasma levels of LH fell rapidly to those of control birds
which had nested throughout the experiment.
Depriving incubating hens of their nests caused an acute reversal of
prolactin and LH secretion resulting in a plasma prolactin and LH
profile similar to that found in laying birds. However, nest-deprived
hens maintain the drive to incubate, which was evident by the acute
reversal of prolaction and LH secretion which occurs after return to the
nest.
4.2 1Steady—state' Concentrations of Hypothalamic Monoamines
Figure 9 shows the concentrations of monoamines in the anterior and
posterior hypothalami of laying, incubating,and nest-deprived-incubating
(NDI) hens.
The concentration of 5-hydroxytryptamine (5HT) in the anterior
hypothalamus was higher in NDI than laying birds and in the posterior
hypothalamus was higher in incubating than NDI birds . Apart from these
differences the concentrations of the individual monoamines did not vary
with endocrine state within either division of the hypothalamus. The
only difference in monoamine content between the two parts of the
hypothalamus was for noradrenaline (NE) which was present at a higher
concentration in the anterior hypothalamus when compared with that in
the posterior hypothalamus of the equivalent groups(p<0.05, unpaired
t-tests, n=8). Any attempt to ascribe physiological significance to
these differences must assume that changes in the concentration of a
particular monoamine, reflects a change in the functional activity of
the neurone system in which that amine functions as a neurotransmitter.













Figure 8: The effect of a 24 hour nest deprivation on plasma levels of
prolactin and luteinizing hormone (n = 6^ SEM). Serial blood samples
were taken from bantam hens deprived of their nests for 24 hours (•—• )
or allowed to continue incubation (o--o). Plasma samples were measured
for prolactin and LH in homologous radioimmunoassays. Selected samples
assayed for prolactin in the heterologous radioimmunoassay showed a





















Figure 9: Monoamine neurotransmitter concentrations in the hypothalamus.
Monoamine concentrations in the anterior hypothalamus and the posterior
hypothalamus of laying (Q), incubating (23) and incubating bantam hens
which had been deprived of their nests for 24 hours (E3) were determined
by electrochemical detection after HPLC. Results are expressed as the
mean + S.E.M. of 8 observations (**-p<0.01, *-p<0.05, unpaired t-test).
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turnover rate in the mammalian hypothalamus (eg. Crowley et al. 1978;
Moyer et al. 1979), questions the validity of this assumption.
Therefore the functional activity of a monoaminergic neurone system is
better assessed as the turnover rate of its monoamine transmitter. In
the present study an index of turnover, which was thought to be
proportional to turnover rate, was used.
4.3 Estimation of Functional Activity
Several non-isotopic methods have been employed to estimate monoamine
turnover rate. In the domestic fowl, the ratio of major metabolite to
parent amine has been used (Juorio and Vogt, 1967). This approach is
limited by the low levels of acid metabolites found in chicken brain
which reflect the presence of a highly effective transport system for
acid metabolites in the avian brain (Ahtee et al. 1970). The levels of
acid metabolites in brain tissue can be enhanced by the administration
of probenecid which blocks the active transport system (Tozer et al.
1966). However, probenecid has been shown to be sedative in chickens at
the dose required to block acid metabolite excretion (Ahtee et al.
1970).While allowing a better assessment of these metabolites, such a
side effect may alter turnover rate. Turnover rate has been estimated
in turkey brain by measuring the decrease in monoamine concentration
after the inhibition of synthesis (El Halawani et al. 1980) and by
measuring the increase in monoamine concentration after the inhibition
of catabolism (El Halawani and Burke. 1976). However, blockade of amine
synthesis or catabolism may cause adaptive changes in the functional
activity of the monoaminergic neurone (von Euler, 1972; Burnstock and
Costa, 1975).
In the present study, two methods were used to estimate turnover.
Firstly,the ratio of monoamine to metabolite was used to estimate the
turnover of 5-hydroxytryptamine (5HT) and dopamine (DA). Secondly, the
accumulation of amine after the inhibition of the catabolic enzyme,
monoamine oxidase with pargyline was used to estimate the turnover of
noradrenaline (NE), adrenaline (A), 5-HT and DA. Although previous
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reports (Tozer et al. 1966; Ahtee et al. 1970) suggest that pargyline
acts as a mild sedative, no sedation was observed in treated birds at
the dose used in this study.
4.3.1 The Ratio of 5-hydroxyindole Acetic Acid (5HIAA) to
5-hydroxytryptamine (5HT)
The concentrations of 5HT and its major metabolite 5HIAA were estimated
in samples of brain tissue by HPLC with electrochemical detection. The
ratio of 5HIAA to 5HT was used as an indicator of the relative
functional activity of 5HT neurones in the hypothalami of laying,
incubating and nest-deprived-incubating (NDI) bantam hens (Fig 10). The
5HIAA/5HT ratio in the anterior hypothalamus was highest in incubating
birds and similar in laying and NDI groups. In the posterior
hypothalamus the ratio was highest in the NDI group while laying and
incubating values were similar. By implication, the patterns of 5HT
turnover in the anterior and posterior hypothalamus were strikingly
different within each group of birds; in laying birds a higher turnover
of 5HT was found in the posterior hypothalamus than in the anterior
hypothalamus (p<0.01, unpaired t-test, n=8). In incubating birds, 5HT
turnover was much higher in the anterior than posterior hypothalamus (p<
0.001, unpaired t-test n=8), while in NDI birds 5HT turnover was higher
in the posterior hypothalamus than the anterior hypothalamus (p<0.001
unpaired t-test n=8).
4.3.2 The ratio of Homovanillic Acid (HVA) to dopamine (DA)
Simultaneous determination of DA and its major metabolite, HVA, in
samples of brain tissue, allowed the calculation of a ratio indicative
of DA turnover rate (Fig 11). In the anterior hypothalamus the ratio of
DA to HVA was higher in incubating birds than in laying or NDI birds
(p<0.01 unpaired t-tests, n=8) and tended to be higher in laying than in
NDI birds. There was no detectable difference in the DA:HVA ratio in
the posterior hypothalami between the three groups. Within each group
the DA:HVA ratio in laying and incubating birds was higher in the
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anterior hypothalamus than in the posterior hypothalamus (p < 0.05,
unpaired t-tests, n=8). No difference was detected between the
anterior and posterior hypothalamus in NDI birds.
It was not possible to assess the turnover of NE or A by this method,
due to difficulty in detecting the very small amounts of
methoxy-3-hydroxyphenylglycol(MHPG) present in the samples and
inconsistency in its retention time after HPLC.
4.3.3 Monoamine Accumulation After Monoamine Oxidase Inhibition
A pilot study was done to determine the rate of amine accumulation in
the chicken hypothalamus after treatment with pargyline. Groups of
pargyline treated birds were killed 0.75, 1.5 and 2.25 hours after
injection, and control groups were killed at time 0 and 2.25 hours
after a saline injection. The concentration of hypothalamic amines
were measured and correlation coefficents and F scores were calculated
after linear regression analysis of the resulting data (see Fig 12).
Linear accumulations of hypothalamic 5HT, DA, NE and A were apparent in
pargyline treated birds for 1.5h while no change in monoamine
concentration occurred in control birds. This finding suggested that
no adaptive changes in monoaminergic neurones occurred in the
hypothalmus as a result of increased amine content after pargyline
treatment over the time period studied. Table 1 summarises the results.
Turnover indices based on the rate of accumulation of the monoamines
following pargyline treatment in the anterior and posterior hypothalamus
of laying, incubating and nest-deprived incubating (NDI) birds are
presented in figure 13.
In the anterior hypothalamus the turnover of noradrenaline (NE) was
similar in laying and incubating birds but was not detectable in NDI
birds. The turnover of NE was similar in the posterior hypothalamus in
all groups of birds. In the anterior hypothalamus, the turnover of
adrenaline was significantly higher in incubating than in laying birds,
but was not detectable in hypothalami from NDI birds. Adrenaline




















Figure 10: The ratio of 5-hydroxyindole acetic acid (5HIAA) to
5-hydroxytryptamine (5HT) in the anterior and posterior hypothalami of
laying (CI), incubating (£2)) and incubating bantam hens which had been
deprived of their nests for 24 hours (£3). The results are the mean +















Figure 11: The ratio of homovanillic acid (HVA) to dopamine (DA) in the
anterior and posterior hypothalami of laying (Q), incubating (£3) and
incubating bantam hens which had been deprived of their nests for 24
hours ( d ). The results are the mean ±, S.E.M. of 8 determinations
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Figure 12: Monoamine accumulation after pargyline injection. The
concentration of hypothalamic monoamine neurotransmitters were
determined in groups of laying hens at intervals following an
intraperitoneal injection of 75 mg/kg pargyline ( • ) or an equivalent
volume of 0.9% saline ( O O ). Results are the mean of eight
observations per time point. See table 1 for statistical analysis.
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Table 1: Monoamine accumulation after pargyline treatment. These are the
results of linear regression analysis of the data presented in Figure
12, and are expressed as the correlation coefficient (r), F-score (F)
and minimum level of significance (df.=23).
r F P
5-hydroxytryptamine 0.54 9.2 0.01
dopamine 0.66 18.1 0.001
noradrenaline 0.42 3.7 0.05




































Figure 13: Indices of monoamine neurotransmitter turnover in the
anterior and posterior hypothami of laying ( Q) , incubating ( (£51) and
incubating bantam hens which had been deprived of their nests for 24
hours (). The index of turnover was calculated by subtraction of the
monoamine concentration in hypothalami from saline treated birds (n=8)
from the monoamine concentration in hypothalami from pargyline treated
birds (n=8) killed 2 hours after injection. (***-p£0.001, *-p<0.05,
unpaired t-test, nd = non-detectable).
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incubating birds than in laying or NDI birds, which had a similar
turnover. Dopamine turnover in posterior hypothalami was similar in
all three groups. In the anterior hypothalami dopamine turnover was
higher in incubating than in laying or NDI birds. The most dramatic
difference in turnover rates between the groups was for
5-hydroxytryptamine (5HT). The turnover of 5HT in the anterior
hypothalamus was much higher in incubating than laying or NDI birds,
while in the posterior hypothalamus, 5HT turnover was significantly
higher in NDI than laying or incubating birds.
The turnover of 5HT and DA measured by amine accumulation after
pargyline treatment closely agrees with that assessed by measuring
amine:metabolite ratios.
4.4 Conclusion : The Influence of Monoamines in the Control of Prolactin
and Luteinizing Hormone Secretion
In the present series of experiments, situations in which LH secretion
was high and prolactin secretion low (i.e. in laying and NDI birds),
were associated with lowered turnover of dopamine, 5-hydroxytryptamine
and adrenaline in the anterior hypothalamus and a low turnover of
adrenaline in the posterior hypothalamus relative to those in incubating
birds. Only in NDI birds was the high level of LH secretion and low
level of prolactin secretion associated with no detectable turnover of
noradrenaline and adrenaline in the anterior hypothalamus and adrenaline
in the posterior hypothalamus. In incubating birds, where the
secretion of LH was low and the secretion of prolactin high, the
turnover of adrenaline, dopamine and 5-hydroxytryptamine in the anterior
hypothalamus and the turnover of adrenaline in the posterior
hypothalamus were high.
The inverse relationship between plasma levels of prolactin and LH
during nest deprivation (Figure 8) and during the transition between
laying and incubating (Lea et al. 1981), suggests a link between the
mechanisms controlling prolactin and LH secretion. The time taken for
these hormonal changes to occur suggests the operation of a long-term
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process governing the transition between laying and incubation, and a
short-term process responsible for the acute changes seen during nest
deprivation.
Previous studies, mentioned earlier (section 1.2.2), suggest that 5HT
stimulates prolactin secretion and inhibits LH secretion, and indicate
that dopamine inhibits, while noradrenaline and adrenaline stimulate the
secretion of both prolactin and LH. However these suggestions are
based on the effects of pharamacological responses which may not reflect
the actions of physiological mechanisms. From the present
observations, it would seem that no single monoamine neurotransmitter is
solely responsible for the regulation of prolactin or LH secretion.
Instead the endocrine changes must be ascribed to net effect of changes
in functional activity of several monoaminergic neurotransmitters.
Changes in the activity of 5-hydroxytryptamine and noradrenaline in the
posterior hypothalamus and noradrenaline in the anterior hypothalamus
may be associated with rapid changes in prolactin and LH secretion,
while changes in activity of adrenaline, dopamine and
5-hydroxytryptamine in the posterior hypothalamus may be associated with
the longer term endocrine changes associated with broodiness.
It is fully acknowledged that an unequivocal assessment of the role of
monoamines in the control of LH and prolactin secretion in terms of
differential turnover in different endocrine states is difficult. Thus,
it can not be assumed that the correlation between monoamine turnover
index and plasma hormone levels implies causality, because of the likely
participation of hypothalamic monoaminergic systems in the regulation of
aspects of hypothalamic function other than the control of prolactin and
LH secretion. It is also acknowledged that monoamine turnover rate
reflects the activity of the pre-synaptic neurone and that the
relationship between released transmitter and its post-synaptic action
may also change in different endocrine states. It was for this reason
that differences in neurotransmitter-receptor characteristics were
investigated in the hypothalami of laying and broody hens. Since the
function of hypothalamic, 5HT and dopamine neurones seem to be most
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affected by the transition from laying to broodiness the hypothalamic
neurotransmitter-receptor systems for 5HT and dopamine were chosen for
further study.
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5.0: 5HT AND DOPAMINE RECEPTORS IN THE HYPOTHALAMUS AND PITUITARY GLAND
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In the previous section the functional activity of aminergic neurones
in the bantam hypothalamus was assessed in terms of neurotransmitter
turnover. Another equally important component of overall functional
activity is the ability of the post-synaptic cell to respond to these
neurotransmitters after their release from nerve terminals. The
physical link between the neurotransmitter and the mechanisms which
cause electrical and biochemical changes within the target cell is a
specific receptor. Therefore the responsiveness of the target cell to
a neurotransmitter is initally dependent on its complement of receptors
for that transmitter. Receptors are regulated by a variety of factors
including the rate of neuronal firing and neurotransmitter release,
hormones from the ovary and pituitary gland, and by other
environmental and neurotrophic influences (see section 1.5).
The correlation between changes in 5-hydroxytryptamine and dopamine
turnover in the bantam hypothalamus and the plasma levels of LH and
prolactin in broody and laying birds prompted a study of putative
5-hydroxytryptamine and dopamine receptors in the hypothalamus and
pituitary gland. Putative receptors were identified by study of the
kinetics of radioligand binding in vitro. It is generally accepted
(Richelson, 1984) that binding sites can be equated with receptor sites
only when the binding can be shown to be associated with a
physiological or pharmacological event, but seldom has this criterion
been met. In much of the literature, 'binding site' and 'receptor' are
used synonymously. This apparent anomaly arises because the primary
biochemical effect of receptor activation has been established for only
a few receptor types in homogeneous and readily available neural
tissues (eg. calf cortex: Burt et al. 1976; and cultured neuroblastoma
cells: Richelson, 1979). The likely heterogeneity of receptor types in
the hypothalamus and the lack of knowledge of molecular events
following receptor activation in this tissue, makes correlation of
radioligand binding with a physiological event difficult. The use of
the correlation of pharmacological manipulation of behavioural or
endocrine events and radioligand binding as a means of receptor
identification, suffers from the likelihood that such events are the
manifestation of interacting systems of neurones. These difficulties
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become further pronounced when interpreting radioligand binding to the
avian brain, because what is known of receptor physiology and the
effects of receptor activation in the mammalian brain may not be
applicable.
In the light of these uncertainties the data presented for radioligand
binding to the hypothalamus and pituitary gland of the the bantam hen
were interpreted with caution.
5.1 5-hydroxytryptamine (5HT) Binding Sites in Bantam Brain
Direct study of 5-HT receptors in the central nervous system began in
the late 1960's (Marchbanks, 1966). The first successful demonstration
of binding to the putative 5-HT receptor in homogenates of brain was
performed by Bennett and Aghajanian (1974) using 3H-lysergic acid
diethylamide. Since then the availability of tritiated 5HT receptor
ligands has prompted many studies of the kinetics and distribution of
the 5HT receptor(e.g.; 3H-5-hydroxytryptamine: Bennett and Snyder, 1975
and 1976; Fillion et al. 1978; Nelson et al. 1978; 3H-lysergic acid
diethylamide: Bennett and Snyder, 1975; Lovell and Freidman, 1976;
Leyson and Laduron, 1977; 3H-methiothepin; Nelson et al. 1979;
3H-PAT; Gozlan et al. 1983). Subtle differences in the binding
characteristics of 3H-5HT, 3H-spiperone and 3H-LSD led to the
proposition that there are two sub-types of 5HT receptor in the
mammalian brain (Peroutka and Snyder, 1979; Seeman et al. 1980). The
5HT^ (agonist) receptor preferentially binds 3H-5HT and the 5HT2
(antagonist) receptor preferentially binds 3H-spiperone. Tritiated -
LSD was chosen as the ligand in the following experiments because of
its ability to bind to both 5HT^ and 5HT,_, receptors with equal affinity
in rat brain (Peroutka and Snyder,1979). The physiological
significance of these two types of 5HT receptor is currently being
investigated (Peroutka and Snyder, 1983).
Specific 3H-LSD binding, assessed by incubation in the presence or
absence of 1 jaM d-LSD, to homogenates of bantam hypothalami was found
to be temperature dependent (Fig. 14A) and reached equilibrium within
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30 minutes (Fig. 14B). These preliminary experiments allowed the
selection of optimum incubation conditions (39°C for 30 minutes), which
were used throughout later experiments. The amount of specific binding
to crude synaptic membrane fractions (CSM) prepared from homogenates of
hypothalami, suggested that the specific binding sites were mostly
localised on cellular membrane fragments rather than in the nuclear
(PI) or microsomal (RP2) cell components (Fig. 14C). As only a low
proportion of specific binding occurred in PI and RP2 fractions the
total particulate pellet was used in all further studies. Specific
(3H)-LSD binding was found to be linear over the range of
concentrations of total particulate preparation routinely used,
(pO.Oi , F test after linear regression, Fig. 14D).
The parameters of 3 H-LSD binding to hypothalamic homogenates are shown
in Fig. 15. Specific binding was found to be saturable within the low
nanomolar range and was monophasic(Fig. 15A). Non-saturable binding
was linear within the range tested. Competitive inhibition studies
(Fig. 15B) demonstrated that the radioligand was bound to 5HT binding
sites. Specific 3H-LSD binding was displaced by low concentrations of
5HT, d-LSD and the 5HT agonist quipazine, in a parallel fashion.
Dopamine only began to inhibit specific 3 H-LSD binding at high
concentrations and displacement did not parallel the other ligands
used. The data presented here established the existence of specific
5HT binding sites in the bantam hypothalamus which could be reliably








































Figure 14: H-LSD binding to homogenates of bantam hypothalami. A: The
effect of temperature on the specific binding of 5mM 3 H-LSD in a 30
minute incubation (mean + S.E.M., n=6). B:The effect of incubation time
on specific 3H-LSD binding at 39° C (mean + S.E.M., n=8). C:Specific
3H-LSD binding to the crude nuclear fraction (PI), the residual
mitochondrial fraction (RP2) and crude synaptic membrane fraction (CSM)
in incubations of 30 mins at 39 C (means + S.E.M., n=8). D:Specific
3 H-LSD binding to various concentrations of homogenate in incubations of
30 minutes at 39 C. Linear regression gave the line of best fit
(p<0.01, F-test, df=29)
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Figure 15: 3 H-LSD binding to homogenates of bantam hypothalami. A:Result
of a typical saturation study, showing plots of calculated specific
binding ( • ), and actual non-specific ( 4^ ) and total binding (O ).
B: Result of a typical inhibition study, showing the effect of various
concentrations of 5HT (• ), d-LSD ( A ), quipazine ( O ) and dopamine (^D) (
). In both cases the points are the mean of 4-6 determinations. The
S.E.M's were less than 5% (not shown).
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5.2 Dopamine Binding Sites in the Bantam Brain
An intensive study of dopamine receptors in the mammalian brain and
pituitary gland was stimulated by several discoveries. These include
the discovery that hyperprolactinaemia can be treated by the
administration of dopamine agonists and that the tuberoinfundibular
dopamine neuronal system plays a key role in the inhibitory control of
prolactin secretion. Also, it was found that Parkinson's disease could
be treated with L-DOPA and that it occurs after pathological
destruction of nigro-striatal dopaminergic pathways. On the basis of
this research, four subtypes of dopamine receptor have been identified
(Seeman, 1982; Cronin, 1982; Creese et al. 1983). However only the
'D2 ' site fulfils all the criteria for a receptor, and is associated
with, or mediates the majority of dopaminergic responses in mammals
(Seeman, 1982).
Studies on the binding of 3 H—domperidone to mammalian nervous tissue
have established that it is selectively bound by dopamine receptors
(Baudry et al . 1979; Sokoloff et al. 1980; Watling and Iversen, 1981).
Because of its low lipophilicity, 3H-domperidone has the advantage over
other dopaminergic ligands of having lower levels of non-specific
binding.Consequently it was used throughout the following experiments.
Initial investigations demonstrated that specific binding of
3
H—domperidone binding to bantam hypothalami, assessed by incubation in
the presence and absence of ljiM domperidone, was temperature dependent
(Fig 16A) and reached equilibrium after 20 minutes (Fig 16B). The bulk
of specific binding was contained in the crude synaptic membrane (CSM)
preparation with low, often undetectable, specific binding to nuclear
(PI) and mitochondrial (RP2) fractions (Fig. 16C). Specific
3
H-domperidone binding to total particulate pellet preparations of
hypothalami was also found to be linear over the range of
concentrations routinely used (p<0.0i, F test after linear regression,
Fig. 16D).
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Figure 16: 3H-domperidone binding to homogenates of bantam hypothalami.
A: The effect of temperature on the specific binding of 3mM
3H—domperidone in a 30 minute incubation (means ± S.E.M., n=6). B:The
3 Oeffect of incubation time on specific H-domperidone binding at 39 C
(means ± S.E.M., n=6). C:Specific 3H-domperidone binding to the crude
nuclear fraction (PI), the residual mitochondrial fraction (RP2) and
crude synaptic membrane fraction (CSM) in incubations of 30 minutes at
39 C (means ± S.E.M., n=8). D:Specific 3H-domperidone binding to
various concentrations of homogenate in incubations of 30 minutes at 39
C. Linear regression gave the line of best fit (p<0.01, f-test, df=29)
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Figure 17A shows that specific 3 H-domperidone binding to homogenates of
hypothalami was saturable at low nanomolar concentrations of ligand and
was monophasic. It was evident from the abilities of various ligands
to inhibit specific binding that 3 H-domperidone labels dopamine
binding sites (Fig 17B). Dopamine, domperidone and (+) butaclamol all
display parallel displacement of 3H-domperidone in low concentrations.
The large difference in potency (approximately 1000 fold) between (+)
butaclamol and (-) butaclamol,demonstrates the stereospecificity of the
3H-domperidone binding site. Only marginal displacement of
3
H-domperidone binding occurred in the presence of high concentrations
of 5-HT.
The data presented here established the existence of specific dopamine
binding sites in the bantam hypothalamus and showed that they were
measurable in the assay system.
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Figure 17: 3H-domperidone binding to homogenates of bantam hypothalami.
A: Result of a typical saturation study, showing plots of calculted
specific binding (• ), and actual non-specific (A) and total binding
(O).BrResult of a typical inhibition study, showing the effect of
various concentrations of dopamine (• ), domperidone (O ), +butaclamol
<!■), -butaclamol ( □ ) , and 5HT ( A ). In both cases the points are the
mean of 4-6 determinations. The S.E.M's were less than 5% (not shown).
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5.3 Receptors in the Anterior Pituitary Gland
Studies of prolactin release in mammals both in vivo and in vitro
suggest that dopamine is a prolactin release-inhibiting factor (see
section 1.2). The use of radioligand binding techniques has proved the
existence of dopamine receptors in the mammalian anterior pituitary
gland and that their activation is inversely correlated with prolactin
secretion (review: Cronin, 1982). There is also evidence for an
inhibitory effect of dopamine at the level of the pituitary gland in
the control of prolactin secretion in birds. Thus, studies on isolated
chicken pituitary glands in vitro show that the stimulation of
prolactin release from the isolated chicken pituitary gland is
inhibited by dopamine (Harvey et al. 1982). Further, 5HT has been
shown to be a potent prolactin releasing agent in birds in vivo (Rabii
et al. 1981), with a direct effect on the isolated pituitary gland
(Border and Chadwick, 1977). If these effects are physiologically
relevant to the control of prolactin secretion in the bantam hen, then
the anterior pituitary gland should contain specific receptors for 5HT
and dopamine.
5.3.1 Lack of Demonstrable Specific 5HT Binding Sites in the Bantam
Anterior Pituitary Gland
In several studies,initially using 3H-5HT and subsequently 3H-LSD, no
specific binding could be detected in preparations of anterior
pituitary glands from either laying or incubating bantams. Large
amounts of non-saturable binding was observed which was not inhibited
_2
by 5HT or d-LSD even in high concentrations (10 M). The complete lack
of any specific 5HT binding sites in the bantam anterior pituitary
gland suggests that the prolactin releasing effect of exogenous 5HT on
the pituitary gland in vitro has little or no relevance to the
physiological control of prolactin secretion. The direct stimulatory
action of 5HT on prolactin secretion from the chicken pituitary gland
in vitro may be due to a non-specific membrane effect of the
transmitter.
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5.3.2 Dopamine Binding Sites in the Anterior Pituitary Glands of Laying
and Incubating Bantam Hens
The ability of homogenates of anterior pituitary glands from laying and
incubating bantam hens to bind 3H-domperidone was assessed. Saturable
specific binding occurred in both tissues and inhibition studies
suggested that 3H-domperidone was bound to specific DA binding
sites(Figs. 18,19). The binding curves(A) showed a monophasic
saturation of specific binding sites at low nanomolar concentrations of
ligand. From the Scatchard plots of these data (B) it was possible to
define the apparent dissociation constant of the binding (K^) and also
the maximal number of binding sites in the tissues (Bmax). The Hill
plots (C), derived from Scatchard analysis, also yield an estimate of
the apparent dissociation (K^) and of the Hill coefficient (Hn), which
assesses the homogeneity of binding. Dopaminergic ligands were found
to displace specific 3H-domperidone binding in a parallel fashion (C).
No differences were observed between pituitary preparations from laying
or incubating hens in the characteristics of the displacement curves
for several ligands used to investigate the specificity of the binding.
The kinetic parameters of these DA binding sites from repeated
independent experiments are given in table 2. The binding sites in the
pituitary glands of laying and incubating birds had similar affinities
(Kp and values not significantly different) and were homogeneous in








Figure 13: Dopamine binding sites in homogenates of anterior pituitary
glands of laying bantam hens. A:An example of the typical saturation
profile of specific binding. B:Scatchard analysis of saturation data.
C: Hill plot of saturation data using the Bmax derived from Scatchard
analysis. D:Inhibition of specific binding by dopamine (•), domperidone
(O ), apomorphine ( □ ), + butaclamol (), - butaclamol ( • ), and 5HT
(A.) (means of 6 determinations S.E.M. less than 5%).
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Figure 19: Dopamine binding sites in homogenates of anterior pituitary
glands of incubating bantam hens. A:An example of the typical saturation
profile of specific binding. B:Scatchard analysis of saturation data.
C: Hill plot of saturation data using the Bmax derived from Scatchard
analysis. D:Inhibition of specific binding by dopamine (•), domperidone
(O), apomorphine (Q), + butaclamol (A), - butaclamol (■), and 5HT
(A) (means of 6 determinations S.E.M. less than 5%).
log free
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Table 2: Dopamine binding sites in the anterior pituitary gland.
The following table was compiled from the results of repeated (n=3-5)
independent saturation and inhibition studies. The apparent
dissociation constant (KD) and number of binding sites (Bmax) were
calculated by Scatchard analysis. Another estimate of KD (KDX) and the
Hill number were also calculated. The concentration at which an
unlabelled ligand displaced 50% of the specific binding (IC50) was
calculated for dopamine (DA), domperidone (DOM), +butaclamol (+BUT),
-butaclamol (-BUT), apomorphine (APO), and 5-hydroxytryptamine (5HT).
Where appropriate results are expressed as the mean TSEM (**-p<0.001,
unpaired t-test)
KD Bmax KDV He
(nM) (fmolmg-1) (nM)
Laying 2.19+0.17 420+32 2. 17+0.2 0.92+0
Incubating 1.87+0.21 238+46** 1.»89+0.3 0.97+0
IC50 (nM)
DA DOM +BUT APO -BUT 5HT
Laying 7 9 100 700 47000 100000
Incubating 8 9 100 850 52000 100000
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The potencies of ligands which inhibit binding were the same in
pituitary gland preparations from laying and incubating birds, and the
low potency of (-)butaclamol suggests that the binding sites were
stereospecific. The only detectable difference between preparations
of anterior pituitaries from laying and incubating birds was the
presence of significantly higher numbers of binding sites (Bmax) in
the laying gland(p<0.01.unpaired t-test).
An interesting analogy exists between mammalian prolactin secreting
pituitary tumours and the incubating chicken pituitary gland, in that
both secrete large quantities of prolactin. The tumours are
.however,refractory to the inhibitory effect of dopamine, suggesting a
change in the mechanism of dopamine action (Cronin et al. 1981).
Radioligand binding studies have shown that the tumours contain
dopamine receptors which have a similar affinity to those found in
normal glands (MacLeod and Cronin 1983). The pathological nature of
such tumours does not allow the comparison of the absolute number of
binding sites they contain, with that in the normal gland. From the
data presented here, it would seem that dopamine binding sites in the
bantam anterior pituitary must be 'down-regulated' in situations of
chronic prolactin release to account adequately for their decrease in
numbers at a time when prolactin release is high. This may reflect a
change in the morphology of the pituitary prolactin cells or may be the
result of an adaptive process minimising the possible prolactin
release-inhibiting effect of dopamine in the incubating bird.A similar
•down-regulation' of dopamine receptors may account for the apparent
refractoriness of the mammalian pituitary tumour.
5.4 Receptors in the Hypothalamus
The correlation between increased turnover of hypothalamic 5HT (Section
4.3) and the development of broodiness in the bantam hen, together with
the evident absence of 5HT binding sites in the pituitary gland
(Section 5.2.) suggests a hypothalamic locus for the action of 5HT. An
pecolblc influence of dopamine through the hypothalamus is also
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possible. The characteristics of dopamine and 5HT binding sites in the
hypothalamus were studied in birds at different stages of the
reproductive cycle.
5.4.1 Hypothalamic 5HT Binding Sites During the Reproductive Cycle
The binding of 3 H-LSD to preparations of anterior and posterior
hypothalami was compared in non-laying, laying, and incubating bantam
hens. Specific, saturable 3H-LSD binding, with displacement
characteristics suggesting it was bound by specific 5HT binding sites,
was found in both parts of the hypothalamus taken from birds at
different stages of the reproductive cycle. Scatchard plots of the
binding curves for all tissues except anterior hypothalami from laying
hens, were linear, suggesting the existence of a single type of 5HT
binding site. In contrast, the Scatchard plots of the binding curve for
preparations of anterior hypothalamus from laying hens were non-linear.
These Scatchard plots were readily resolved into two components
suggesting the existence of two binding sites (Keightley et al. 1983).
A Hill plot of the data confirmed the difference in apparent affinity.
Typical Scatchard plots of data from saturation curves from experiments
using anterior hypothalami of laying and incubating bantam hens are
presented in figure 20A and 20B respectively.
The inhibition of specific 3H-LSD binding to preparations of anterior
hypothalami from laying birds by 5HT was bimodal, whereas the
inhibition of binding to preparations of posterior hypothalami from
laying birds and to anterior and posterior hypothalami from incubating
birds was monophasic. This was further evidence of the existence of
two 5HT binding sites of different affinities in the anterior
hypothalamus of the laying bird. Examples of data from inhibition
experiments using anterior hypothalami from laying and incubating hens






















Figure 20: 5HT binding sites in the anterior hypothalamus. A:Scatchard
plot of saturation data for specific 3 H-LSD binding to homogenates of
anterior hypothami from laying bantam hens. B:Scatchard plot of
saturation data for specific 3 H-LSD binding to homogenates of anterior
hypothalami from incubating bantam hens. C:Inhibition of specific
binding to homogenates of anterior hypothalmi from laying birds by 5HT
(•) and d-LSD (o) (means of 12 observations, S.E.M.< 5%). D:Inhibition
of specific binding to homogenates of anterior hypothalami from
incubating birds by 5HT ( • ) ad - LSD ( O ) (means of 12 observations,
S.E.M.'s<5%)
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In the absence of additional information concerning the possible
differential ligand preferences of these two co-existing 5HT binding
sites in the anterior hypothalamus of the laying bird, their
interrelationship can be expressed in a number of ways :
1. The binding sites may represent two independent receptor types,
and can be described as follows;
+ L = RjL
R2 + L = R2 L
Where and R2 are receptors and L is the ligand.
2. The binding sites may be part of the same receptor and their
interaction may show some degree of cooperativity. In its
simplest form this interaction can be described as follows;
R2 + L = R2L + L = R2L2
Apart from sequentially cooperative interaction, like that described
above, more complex interactions involving concerted cooperativity and
further receptor activation after initial binding may also occur
(Boeynaems and Dumont, 1980).
An attempt was made to determine whether the two 5HT binding sites
were independent, by investigating the possibility that one of the
binding sites was located on neurones containing 5HT. This was achieved
by treating laying bantam hens with the 5HT neurotoxin
p-chloramphetamine(pCA).
Chronic treatment with p-chloramphetamine (pCA) resulted in a 72%
decrease in 5HT, and the complete disappearence of 5-hydroxyindole
acetic acid in the hypothalamus (Fig. 21A). The catecholamine content
of the hypothalamus was not affected. These findings are consistent











Fxgure 21: A:concentrations of noradrenaline (NE), dopamine (DA),
5-hydroxytryptamine (5HT) and 5-hydroxyindole acetic acid (5H1AA) in
anterior hypothalami from laying bantam hens treated with saline
(Q) or p-chloramphetamine (W3\) . Results are the means + SEM of 6
observations (***-p<0.001, unpaired t-test). B:scatchard plot of
saturation studies of 3 H-LSD binding to homogenates of anterior
hypothalami from PCA treated laying hens. C:inhibition, by 5HT (• ) and
d-LSD ( O ), of specific 3 H-LSD binding to homogenates of anterior
hypothalami from PCA treated laying hens (means of 8 observations, SEM
less than'5%).
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destroyed hypothalamic 5HT neurones. Repeated studies of 3H-LSD
binding to preparations of anterior hypothalami from pCA treated birds
consistently showed saturable specific binding which gave a linear
plot on Scatchard analysis (Fig. 21B). Further evidence that only one
5HT binding sites was present in this tissue comes from the monophasic
nature of the inhibiton of specific 3H-LSD binding by 5HT(Fig. 21C).
However, the kinetics of the remaining binding sites did not resemble
CK
either of those which occurred in anterior hypothalami from laying
birds. This may have been due to adaptive changes in the regulation of
5HT receptors in response to decreased 5HT tone. These findings
suggest that one of the two 5HT binding sites in anterior hypothalami
from laying birds is located on 5HT neurones, while the other is
located post-synaptically. Therefore it is likely that the two sites
represent independent putative 5HT receptors which conform to simple
occupancy theory.
The results of repeated independent studies of 3 H-LSD binding to
preparations of hypothalami are given in Table 3. In summary, a
homogeneous population of 5HT binding sites of similar affinity and
number were found in the posterior hypothalamus of laying,incubating
and out-of-lay birds. In the anterior hypothalamus, a second
population of 5HT binding sites possibly located on 5HT neurones, was
observed only in laying birds. Other binding sites for 5HT were
present in preparations of anterior hypothalami from laying, incubating
and out-of-lay birds, and had similar affinities and numbers.
5.4.2 Hypothalamic Dopamine Binding Sites During the Reproductive Cycle
The specific binding of 3H-domperidone to anterior and posterior
hypothalami was compared in preparations from laying and incubating
bantam hens. Specific, saturable 3H-domperidone binding with
displacement characteristics suggesting dopamine binding sites occurred
in both parts of the hypothalamus in both physiological states. In
repeated experiments Scatchard plots of saturation data were linear.
Hill plots of binding data confirmed that 3 H-domperidone was bound by a
single non-interactive site. The results of repeated independent
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Table 3: 5HT binding sites in the hypothalamus.
The following table was compiled from the results of repeated (n=4-6)
independent saturation studies. The apperent equilibriation
dissociation constant (KD) and the number of binding sites (Bmax) were
calculated by Scatchard analysis. The dissociation constant (KDN) and
the Hill number (He) were also calculated by Hill analysis.
ANTERIOR
HYPOTHALAMUS



















































studies are given in Table 4. Inspection of the apparent affinity of
binding (K^ and K^) and the number of binding sites (Bmax) showed that
dopamine binding sites existed throughout the bantam hypothalamus and
that they were kinetically similar in both laying and incubating birds.
5.5 Conclusion: Implications of changes in putative 5HT and DA
receptors during the reproductive cycle
High affinity binding sites for 5HT occurred in large numbers
throughout the bantam hypothalamus. In the anterior hypothalamus of
laying birds two kinetically different 5HT binding sites were present.
Only one type of 5HT binding site was found in all other tissues
studied and the data from pCA treated birds suggest that one of the
sites present in the laying anterior hypothalamus was located on 5HT
neurones. No specific 5HT binding sites were detected in the anterior
pituitary gland.
The presence of 5HT binding sites on 5HT neurones in the anterior
hypothalamus of laying birds and their apparent absence in the anterior
hypothalamus of incubating birds suggests a mechanism by which 5HT
turnover in this area is regulated. If it is assumed that the
population of 5HT receptors unique to laying birds consists of
pre-synaptic autoreceptors and is responsible for an inhibition of 5HT
neurones, then during the transition between laying and incubation the
disappearance of this population could result in an increase in 5HT
turnover (see section 4). A possible mechanism for the change in 5HT
binding sites in the anterior hypothalamus may be related to the drop
in gonadal steroid production seen at the onset of incubation (Sharp et
al. 1979) or the initial rise in prolactin secretion acting either
directly in the hypothalamus or indirectly by inhibiting ovarian
steroidogenesis.
High affinity dopamine binding sites were present in low numbers
throughout the bantam hypothalamus and no differences in their kinetics
were detected between laying and incubating birds. High affinity
dopamine binding sites were present in large numbers in the anterior
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Table 4: Dopamine binding sites in the hypothalamus.
The following table was compiled from the results of repeated (n=4)
independent saturation studies. The apparent equilibriation
dissociation constant (KD) and the number of binding sites (Bmax) were
calculated by Scatchard analysis. The dissociation constant (KD*) and

















pituitary glands of laying hens and were also present, although in
significantly lower numbers, in the anterior pituitary glands of
incubating hens. This difference may also be attributable to changes in
the plasma levels of gonadal steroids at the onset of incubation.
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PHAR^MAl6.0 P A ACOLOGICAL MANIPULATION OF PROLACTIN SECRETION
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The aim of the following experiments was to examine the influence of
5HT on the control of prolactin secretion in laying and incubating
bantam hens. Several drugs were used to manipulate 5HT function in
vivo and their assumed modes of action are shown in Figure 22. The
effect of the 5HT agonist, quipazine, on prolactin release from the
isolated pitiutary and pituitary/hypothalamus co-incubations, was also
assessed. Prolactin concentrations in plasma samples and in samples
of incubation media were assessed by an homologous chicken prolactin
radioimmunoassay (Scanes et al. 1976). The prolactin content of
selected samples was also measured in the heterologous prolactin
radioimmunoassay (McNeilly et al. 1978). The specificity of the
homologous radioimmunoassay was investigated after separation of the
protein constituents of samples of incubation media by polyacrylamide
gel electrophoresis.
6.1. Drug Treatments in vivo
6.1.1 The Effect of Manipulations of 5HT Systems on Plasma Levels of
Prolactin measured in the Homologous Radioimmunoassay
In the laying bantam hen, the 5HT agonist, quipazine, stimulated the
release of prolactin in a dose related manner (Fig. 23A), confirming
previous observations in immature chickens (Rabii et al. 1981) and
turkeys (El Halawani et al. 1983). Pre-treatment of the birds with the
5HT receptor blockers meth^ysergide, cyproheptadine, and SQ 10631,
reduced the quipazine stimulated release of prolactin (Fig. 23B),
showing that 5HT receptor activation was the basis of the prolactin
response to quipazine. Prolactin release was also stimulated in laying
bantams by injections of the immediate precursor of 5HT,
5-hydroxytryptophan (Fig. 23C). The stimulatory effect of
5-hydroxytryptophan on prolactin release was reduced by pre-treatment
of the birds with the 5HT receptor blocker, cyproheptadine, and
enhanced by the specific 5HT reuptake blocker, fluoxetine (Fig. 23D).
Fluoxetine alone had no effect on plasma levels of prolactin and did












Figure 22: Assumed modes of action of drugs used in vivo
1. Administered 5HTP enhances the release of 5HT by providing
additional substrate 5HT synthesis. P.Quipazine selectively stimulates
5HT receptors thus mimicking the effect of endogenous 5HT.
3. Cyproheptadine, SQ 10638, and methysergide selectively block 5HT
receptors thus diminishing the effect of endogenous 5HT. 4.Fluoxetine
selectively blocks the specific 5HT reuptake system thus prolonging the
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Figure 23: Pharmacological manipulations of plasma levels of prolactin.
A: The effect of jingle intraperitoneal injections of quipazine at 15(*)
io lo} ,and 5 mg kg , or saline ( A ) on plasma levels of prolactin in
groups (n=6) laying bantam hens. B: The effect of pre-treatment of
laying bantam hens with £aline methysergide (10 mg kg ), cyproheptadime
(10 mg kg ) or SQ 10638 (10 mg kg ) 30 minutes before an injection of
saline (15 mg kg ). Blood samples were taken by
hours after the second injection. C:the effect of a
or quipazine
venepuncture 2
single^intraperitoneal injection of 5-hydroxytryptophan at 50 (•) or 25
mg kg (O) or acidifie£d saline ( ) on plasma levels of prolactin
in g£^r\ips (n=7) of laying bantam hens. D: The effect of pre-treatmejt of
gbups of laying henjp (n=6) with saline, cyproheptadine (10 mg kg ) or
fluoxetine (lOmgkg ). ^Thirty minutes before an injection of acidified
saline or 5-HTP (50mgkg ). Blood samples were taken by v/enepuncture 2
hours after the second injection. °
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suggested that 5-hydroxytryptophan acted via 5HT neurones to promote
the release of 5HT, which in turn stimulated prolactin secretion.
However, a direct effect of 5-hydroxytryptophan on the 5HT receptor may
also occur. The finding that fluoxetine did not influence the effect
of quipazine, further confirms that quipazine acts by directly
stimulating 5HT receptors.
The stimulatory action of quipazine on prolactin release was
significantly reduced (p<0.01, unpaired t-test, 120 minute samples),
and 5-hydroxytryptophan failed to stimulate prolactin secretion, in
nest-deprived incubating birds (Fig. 24A). These results suggest that
although 5HT stimulates prolactin secretion in the laying hen, its
physiological importance in the release of prolactin during incubation
may be small. Also, of the 5HT receptor blockers tested, only
methysergide was effective in lowering the plasma levels of prolactin
of incubating birds (Fig. 24B). The fact that methysergide can
stimulate dopamine receptors as well as block 5HT receptors (Krulich et
al. 1981) may explain this result. The reduction of plasma levels of
prolactin in incubating hens by methysergide may reflect its ability to
stimulate dopamine receptors in the pituitary gland, as dopamine has
been shown to inhibit the stimulated release of prolactin from the
isolated chicken (Harvey et al. 1982) and pigeon (Hall, 1982) pituitary
glands.
The differences in responsiveness between laying, and
nest-deprived-incubating birds to quipazine, 5-hydroxytryptophan,
cyproheptadine and SQ 10631 suggests that hypothalamic 5HT is less
important in the stimulation of prolactin release in broody than in
laying birds. Further, it suggests that the extrapolation of theories
of the neuroendocrine control of broodiness based solely on studies in





Figure 24: Pharmacological manipulations of plasm|i levels of prolactin.
A: the^effect of a single injection of 15 mg kg quipazine (circles),
50mgkg 5HTP (squares) or saline (triangles) on plasma levels of
prolactin in groups (n=8) of laying (solid lines) or incubating bantam
hens that had been deprived of their nests for 24 hours (broken lines).
Results are the mean^ + SEM. B: The effect of a ^single injection of
saline (& ), 15mgkg " cyproheptadine (O) or 15mgkg methysergide (•Jon
plasma levels of prolactin in groups (n=8) of incubating bantam hens.
Results are the mean ± SEM, *p<0.05 compared with preceding point,
(paired t-test).
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6.1.2.The effect of manipulation of 5HT activity on plasma levels of
prolactin measured in the heterologous radioimmunoassay
When selected plasma samples were assayed for prolactin content in the
heterologous radioimmunoassy, neither quipazine nor 5-hydroxytryptophan
treatment elevated plasma levels of prolactin in laying bantam hens
(Table 5). Conversely, the heterologous radioimmunoassay detects an
acute elevation in plasma levels of prolactin after administration of
porcine vasoactive intestinal polypeptide (See section 7), which the
homologous assay does not. Figure 25 shows the result of measuring
plasma samples from quipazine, 5-hyroxytryptophan and porcine VIP
treated birds in both assay systems. Although the homologous and the
heterologous radioimmunoassays are highly correlated when measuring the
rise in plasma level of prolactin which occurs at the onset of
incubation (Lea, 1982), no correlation exists after the drug
treatments.
6.2 Effect of Quipazine on Prolactin Secretion In Vitro
The effect of quipazine on prolactin secretion was assessed in vitro by
incubating the drug with pituitary glands and hypothalami from laying
bantam hens either alone or together and measuring prolactin released
into the incubation media. Prolactin was measured using both the
homologous and heterologous radioimmunoassays to confirm their
specificities.
Using the homologous radioimmunoassay, quipazine had no effect on the
release of prolactin from isolated pituitary glands(Fig. 26A).
Prolactin release was stimulated in pituitary/hypothalamus
co-incubations and this release was enhanced in the presence of
quipazine. The isolated hypothalamus released prolactin in the absence
of quipazine, and this release was not enhanced after the addition of
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Figure 25: Comparison of homologous (Scanes et al 1976) and heterologous
(McNeill^y et al 1978) prolactin radioimmunoassays. Plasma taken
samples from bantam hens immediately prior to, and at intervals up to 2
hours after, a single injjpction of auipazine (15mgkg , squares),5-hydroxyt^ptophen (|>Omgkg , triangles) or vasoactive intestinal
polypeptide (lOOmgkg , circles) were measured for prolactin content in
both assays. Lines of best fit calculated by linear regression (p<0.01,
f-test) ran parallel with both axes.
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Table 5: Comparison of the two prolactin assays. Plasma samples from
groups (n=8) of laying bantam hens taken immediately before and 2 hours
after a single injection of quipazine or 5-hydroxytryptophan (5HTP)
were assayed for prolactin content in both the homologous and
heterologous RIAs. The results are expressed as means + SEM.
Significant differences between mean prolactin levels at injection and
120 min later are marked by '*'. (*-p<0.001 ,paired t-test).
TREATMENT PLASMA PROLACTIN(ngml *) ASSAY
0 mins 120
QUIPAZINE (15 mgkg *) 20.9+6.1 125.3+12.6* homologous
8.6+2.7 heterologous9.3+3.1
5HTP (50 mgkg 1) 23.4+5.2 87.3+15.6* homologous
10.2+4.1 heterologous8.2+2.5
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With the heterologous radioimmunoassay, quipazine had no effect on the
release of prolactin from isolated pituitary glands. Prolactin release
was not stimulated in pituitary/hypothalamus co-incubations in the
absence or presence of quipazine (Fig 26C). Only relatively small
amounts of immunoreactive prolactin were detected in incubations of
hypothalami alone (Fig 26D).
These findings, together with those in the previous section, suggest
that the homologous radioimmunoassay detects an immunologically active
substance released from the hypothalamus ,the secretion of which may be
stimulated by activation of 5HT receptors. This possibility was
further investigated using polyacrylamide-gel electrophoresis, to



































Figure 26: The effects of q^£>azine on prolactin secretion in vitro. The
concentration of prolactin released during incubations of anterior
pituitary glands (PIT),1^ anterior pituitary glands and basal hypothalami
(PIT/HYP), and hypothsjmi alone (HYP) in the presence ( 0) and absence
( Q ) of 10 M quipazine was measured in the homologous and heterologous
radioimmunoassays. Results are the mean ±. SEM of 6 independent
observations (*p*0.05, unpaired t-test).
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6.3 Polyacrylamide Gel Electrophoresis
Proteins in incubation media and aqueous extracts of anterior pituitary
glands and neurohypophyses were separated by discontinuous
polyacrylamide gel electrophoresis. Examples of the typical banding
patterns seen after protein staining are shown in figure 27. One tract
of two paired samples was stained to give the banding pattern while the
other was cut into slices representing 0.05 Rf units and the proteins
eluted from each finely homogenised slice. By assaying aliquots of the
resulting eluent in the homologous radioimmunoassay 'prolactin'
immunoprofiles were constructed. More than 90% of total
immunoreactivity was found in the lower portions of the gels (Rf values
0.4). Peaks of immunoactivity correlated well with protein bands
observed in the stained gel. A summary of the results in terms of the
observed banding patterns and relative immunological activity
associated with each band is given in figure 28.
An immunoactive protein band (Rf = 0.55) was present in all samples
studied. The proportion of total immunoactivity concentrated in this
band is higher in incubation media from isolated hypothalami and neural
lobe extracts, than in anterior pituitary gland extract. An
immunoactive protein band of Rf = 0.65 was also present in samples of
neural lobe extract. Only samples from incubations containing
pituitary glands from laying birds, co-incubations of pituitary glands
from incubating birds with hypothalami and pituitary gland
extract,contained a strongly immunoreactive protein band of Rf =0.75.
An immunoreactive protein band of Rf =0.95 occurred only in samples
containing pituitary glands from incubating birds.
In the system used, anterior pituitary gland extract contains 4
electrophoretically distinct proteins which make up its
immunoreactivity in the homologous prolactin radioimmunoassay. Samples
of medium from incubations containing isolated pituitary gland from
laying birds contain two of these proteins (Rf = 0.55 and 0.75),
suggesting that the proteins of Rf =0.45 and 0.60 in the pituitary
extract are not normally released by the gland. However, both neural
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Figure 27: Photograph of stained gel. Anterior pituitary gland extrac
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Figure 28: Banding patterns and immuno profiles after poly acrylamide
gel electrophoresis of; A:anterior pituitary gland extract (n=4/2).
B: neural lobe extract (n=4/2). C:incubation media of pituitary glands
from laying hens (n=6/3). D:incubation media of basal hypothalami from
laying hens (n=6/3). E:incubation media of co-incubation of pituitary
glands and basal hypothalami from laying hens (n=6/2). F:incubation
media of pituitary glands from incubating bantam hens (n=6/3).
G: incubation media of co-incubations of pituitary glands and basal
hypothalami from incubating hens (n=6/2).
The first number in parenthesis refers to the number of banding patterns
studied while the second refers to the number of immunoprofiles
constructed.
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lobe extract and samples of media from incubations of isolated
hypothalami also contain an immunoreactive protein of Rf = 0.55 which
is electrophoretically indistinguishable from that seen in samples of
pituitary gland incubations. An electrophoretically distinct
immunoreactive protein (Rf = 0.65) released by the hypothalamus and
which is present in neural lobe extract, does not occur in samples of
pituitary gland incubations.
The differences between the proteins released by incubations of
pituitary glands of laying and incubating birds, which make up the bulk
of the immunoactivity in these samples, may reflect a difference in the
molecular forms of releasable prolactin that are dependent upon
physiological state. The presence of immunoreactive proteins of Rf =
0.95 in samples from coincubations of pituitary glands from incubating
birds and hypothalami may also suggest a role for the hypothalamus in
governing the type of prolactin secreted by the pituitary gland.
6.4 Conclusion: Implications for the Interpretation of Prolactin
Radioimmunoassay Data
In a detailed study of the characteristics of the homologous prolactin
radioimmunoassay, Lea (1982) found that immunoreactive 'prolactin' was
present in extracts of hypothalamic tissue and present in large
quantities in neural lobe extracts, as well as in the anterior
pituitary gland. However, the amount of immunoreactive prolactin in
hypothalamic extracts was less than the estimated total immunoactivity
found in chicken plasma after intravenous injection of hypothalamic
extract. The results of the present study confirm and extend these
observations. Not only is immunoreactive prolactin present in the
hypothalamus, it can be released in vitro and consists of two
electrophoretically distinct components. Immunoreactive prolactin in
anterior pituitary gland extract occurs as four major components, only
two of which appear to be released in vitro. One of the components
releasedby the pituitary was electrophoretically indistinguishable from
one of the releasable hypothalamic proteins but neither are
immunologically
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distinct. Three immunologically active components are released by the
pituitary and hypothalamus in co-incubation which reflects the sum of
components released by the pituitary and hypothalamus when incubated
alone.
On the basis of these findings, plasma prolactin levels in vivo and
prolactin released during pituitary/hypothalamus co-incubations
measured by the homologous radioimmunoassay, may reflect the sum of
immunologically active proteins released by the hypothalamus and neural
lobe, as well as prolactin released from the anterior pituitary gland.
The heterologous prolactin radioimmunoassay also detects prolactin-like
immunoreactivity in extracts of chicken hypothalamus and neural lobe
(Lea, 1982). However , this assay system detects only small amounts of
immunoactivity released by the hypothalamus in incubation (Fig. 26D),
which suggests that the immunoactivity it detects in hypothalamic
extract is not released upon incubation of the hypothalamus. Thus the
heterologous assay may be able to differentiate between prolactin
released from the pituitary gland and substances released from the
hypothalamus, that are immunoactive in the homologous system. A
corollary of this possible difference between the two assay systems is
the inability of the heterologous system to detect acute changes in
plasma levels of prolactin after the administration of drugs which
modify 5HT systems. These drug treatments are functionally
non-specific since it is certain that not all 5HT neuronal systems are
involved in the control of prolactin secretion and that the drugs used
affect all 5HT systems. Further, because the homologous assay measures
more than one immunoreactive substance it too can be considered as
non-specific, as the balance of immunoreactive components released
after drug administration may be altered dramatically.
However, the two assay system show strong positive correlations in
situations where prolactin secretion is changed by an endogenous
mechanism, as for example, during the transition between laying and
incubating( Lea et al. 1981) and during nest deprivation(section
4.1.1).
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Although 5HT may be involved in the physiological control of prolactin
secretion in the chicken, its importance has perhaps been overestimated
due to the assumption that immunologically active material released by
drug action and detected by the homologous assay, is solely prolactin
originating from the pituitary gland.
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7.0 VASOACTIVE INTESTINAL POLYPEPTIDE AS A SPECIFIC
PROLACTIN-RELEASING FACTOR IN THE BANTAM HEN
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The aim of the following experiments was to determine in the bantam
hen,whether neurones containing VIP-like immunoreactivity occur in the
hypothalamus , and if so, to assess the effects of VIP on the release
of prolactin in vivo and from the anterior pituitary gland in vitro.
7.1 The Distribution of VIP—Like Immunoreactivity in the Hypothalamus
The following section describes the immunohistochemical distribution of
VIP-like material in the adult bantam hypothalamus. The distribution
of neurones and terminals containing VIP-like immunoreactivity was
plotted on the para-sagittal and transverse planes used by Sterling and
Sharp (1981) in their study on the distribution of LHRH (Fig. 29).
7.1.1 The Mediobasal Hypothalamus
Small VIP-immunoreactive perikarya were present throughout the caudal
portion of the infundibular nuclear complex and the lateral tuberal
area (Fig. 29.F.). These cells were usually bi-polar, and the majority
were orientated in a dorso-ventral plane. The immunoreactive reaction
product was granular in appearance and was dispersed evenly throughout
the cytoplasm and axonal processes of the cells. No reaction product
was seen in the cell nuclei (13 2>o)
Heavily immunoreactive beaded fibres were present in the region of the
perikarya. Fibres originating from the infundibular nuclear complex
were seen to run laterally and ventrally, entering the median eminence
by skirting the lateral horn of the infundibular recess and forming
part of the tubero-hypophyseal tract described by Yamada and Mikami
(1982). Small fibres and characteristically punctate
VIP-immunoreactive terminals were abundant in the external layers of
both the anterior and posterior median eminence. Fibres and terminals
were observed in close apposition to capillary blood vessels in the
anterior median eminence. Little immunoreactive material occurred in
the internal layer of the median eminence ( X-e. Z&}
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Figure 29: The Distribution of VIP-like immunoreactivity In The Bantam
Brain. VIP was located immunohistochemically in para-sagittal sections
of 5 preparations and transverse sections of 7 preparations and plotted
on sagittal and transverse representation of the brain (Sterling and
Sharp, 1982). Cells are represented by dots, fibres by dashes and






Figure 30: Photomicrographs of VIP-like immunoreactivity.
A. Transverse section through the mediam eminence (xlO).
B. Sagittal section through the median eminence (x40).
C. Fibres in the pre-optic region (x20).
D. Cells in the infundibular neuclear complex (xlO).
E. Cells in the infundibular neuclear complex (x40).
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7.1.2 The Mid-Hypothalamus
A few VIP-immunoreactive perikarya were observed in the region lateral
to the paraventricular organ (Figure 29.E,F). No liquor-contacting
processes were observed but dense fibre staining occurred in this
region. Fibres spread laterally from these cells to the area of the
nucleus mammilaris lateralis and seemed to project forwards towards the
anterior hypothalamus as well as descend towards the median eminence.
7.1.3 The Anterior Hypothalamus
A few small VIP-immunoreactive perikarya were observed in the
medio-basal preoptic region (Fig 29.A). This area was rich in
VIP-containing fibres and terminals which occurred in a broad band from
above the pallial commissure and septal nuclei through the region of
the anterior commissure to the lamina terminalis. The lamina
terminalis contained an abundance of immunoreactive terminals (Fig.
29.B).Long beaded fibres running rostro-caudally between the pre-optic
region and the tuberal area were observed in the area of the
supra-optic tract and ventromedial nucleus(Fig. 29.B,C,D).
7.1.4 Discussion and Summary
It has been suggested that the tuberohypophyseal tract in birds
consists of three distinct elements (Wingstrand 1951; Oksche and
Farner, 1974). The VIP-immunoreactive neurones with cell bodies in the
infundibular nuclear complex in both the bantam and quail hypothalamus
(Yamada and Mikami, 1982) form tracts which correspond to the medial
bundle of the tubero-hypophyseal tract, which passes along the margin
of the third ventricle, and the lateral bundle, which passes along the
ventral surface of the hypothalamus (Wingstrand 1951). Also, the
VIP-immunoreactive perikarya close to the nucleus mammilaris lateralis
send fibres to the median eminence along the posterior bundle of the
tubero-hypophyseal tract (Oksche and Farner, 1974). All three
divisions of the tubero-hypophyseal tract terminate in the external
layer of the median eminence. The dense distribution of
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VIP-immunoreactive fibres and terminals located in the bantam median
eminence contrasts with the sparse distribution found in mouse and rat
median eminence (Sims et al. 1980). The presence of VIP-immunoreactive
terminals close to the portal capillaries in the median eminence
suggests that VIP-like material is secreted into the portal vessels.
Evidence of possible interaction between the VIP-like system and those
of 5-hydroxytryptamine and catecholamine containing neurones, comes
from the overlap in their anatomical distribution in the hypothalamus
and median eminence(see section 3). The distribution of VIP-like
immunoreactive neurones also coincides with the distribution of LHRH
perikarya and terminals(Sterling and Sharp 1981), and with fibres
containing somatostatin (Blasher ,1983) and neurotensin (Yamada and
Mikami, 1981). In summary, neurones containing VIP-like
immunoreactivity occur in the bantam hypothalamus with a distribution
consistent with a role in the regulation of hormone secretion from the
anterior pituitary gland. This regulatory role may involve a direct
effect of VIP released into the portal vessels acting directly on the
pituitary gland and/or interaction of VIP fibres with other peptidergic
or monoaminergic systems in the median eminence and the hypothalamus.
7.2 The Effect of VIP on the Pituitary Gland in vitro
The effect of porcine VIP on prolactin release from the isolated
_7
pituitary gland is demonstrated in Figure 31. The presence of 10 M
porcine VIP in the incubation medium had no effect on prolactin
secretion from pituitary glands from laying hens, but significantly
stimulated (p<0.001, unpaired t—test) prolactin release from pituitary




Figure 31: Effect of porcine VIP on prolactin secretion from pituitary
glands incubated in vitro. Pituitary_ glands for laying and incubating
bantam hens were incubated in the pres^ence ( *23) or absence (□) of 10
M VIP. The prolactin content of ""the medium was assessed in the
heterologous radioimmunoassay. The results are expressed as the mean +
SEM of eight observations, (** = p<0.001, unpaired t-test).
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7.3 The Effect of VIP on Hormone Secretion In Vivo
Plasma samples from a series of experiments in which porcine VIP was
administered to laying, nest-deprived-incubating (NDI) and
ovariectomised bantams were assayed for prolactin content by the
heterologous radioimmunoassay, for LH content by a homologous
radioimmunoassay and for growth hormone content by a homologous
radioimmunoassay.
7.3.1 Time Course
Plasma levels of prolactin , LH and GH were assessed in NDI bantam hens
after administration of 100 yug kg ^ porcine VIP (Figure 32). Two
minutes following injection plasma levels of prolactin were
significantly elevated compared with their pre-injection values
(p<0.01, paired t-test) and those of saline injected birds (p<0.01,
unpaired t-test). Plasma levels of prolactin in VIP treated birds
continued to rise to a peak ten minutes after injection, which was 14
fold higher than control values. A gradual decline occurred over the
following twenty minutes, bringing prolactin levels in VIP treated
birds close to those of control birds 30 minutes after saline
injection. The plasma levels of LH in VIP treated birds were also
significantly increased above those in control birds two minutes after
injection (p<0.05, unpaired t-test). The stimulation of LH secretion,
although equally acute in onset, was of a lesser magnitude and less
sustained than the stimulation of prolactin secretion. Ten minutes
after injection, plasma levels of LH in VIP treated and control birds
were statistically indistinguishable. Plasma levels of GH showed large
individual variations and when grouped together plasma levels of GH in
VIP treated birds did not significantly differ from those found in









































Figure 32: Effect of VIP on plasma levejs of prolactin, luteinizing
hormone (LH) and growth hormone (GH) in vivo.Groups of incubating bantam
hens (n=5) which had been deprived of their r^epts for 24 hc^urs were
injected intravenously with either 0.75% saline^or 100 ftg kg porcine
VIPC^- Blood samples were taken immediately before and 2, 5, 10, 15 and
30 minutes after injection. Plasma samples were assayed for prolactin
content in the heterologous RIA and for LH and GH in the homologous
RIA's. The results are expressed as means + SEM.
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7.3.2 Dose-Response Relationship
The effect on plasma levels of prolactin, LH and GH of various doses of
VIP was determined in NDI bantam hens. All doses tested above and
including 12.5 pg kg ^ of VIP, significantly elevated plasma levels of
prolactin 10 minutes after injection when compared with those 10
minutes after a control injection of saline (Figure 33). No increase
in plasma levels of LH or GH were observed 10 minutes after VIP
injection. Plasma levels of LH and GH in birds before and 10 minutes
after injection of 50 and 100 jug kg ^ are given below;
Table 6: The effect of VIP on plasma levels of LH and GH.
Dose of VIP Plasma LH Plasma GH
—1 —1 —1
(pg kg ) (ng ml ) (ng ml )
0 10 0 10
0 2.10 + 0.40 2.04 + .032 1.6 + 0.7 1.7 + 0.5
50 2.24 + 0.35 2.19 + 0.30 1.3 + 0.4 1.2 + 0.3
100 1.80 + 0.40 2.71 + 0.50 1.8 + 0.6 1.9 + 0.7
Figures are for plasma luteinizing hormone (LH) and growth hormone (GH),
before (0) and 10 minutes after (10) injections of VIP, and are the mean
of 5 observations + S.E.M.
7.3.3 The Effect of VIP on Plasma Levels of Prolactin in laying,
Nest-Deprived-Incubating and Ovariectomised Bantam Hens
Groups of laying, nest-deprived-incubating (NDI) and ovariectomised
birds were injected with 50 jag kg porcine VIP. Injections of VIP
significantly elevated plasma levels of prolactin in laying and NDI but
not in ovariectomised birds (Figure 34). The magnitude of the rise in
plasma levels of prolactin was significantly greater in NDI than laying
birds (p<0.01, unpaired t-test). Plasma levels of LH and GH were
unaffected by VIP treatment.
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Figure 33: Dose response relationship. Groups of incubating bantam hens
which Jiad been deprived of their nests for 24 hours were injected
intrav/enously with either 0.7% saline (O ) or various doses of porcine
VIP (3.25 - 100jfi,ig kg ). Blood samples taken immediately prior to and
10 minutes after injection, were assayed for prolactin in the
heterologous RIA. The results are expressed as the incremental rise in
plasma level of prolactin and are the mean t SEM's of 5 observations.
The lowest dose of porcine VIP that significantly stimulated prolactin






Figure 34: The effect of porcine VIP on plasma prolactin in laying,
nest-deprived incubating and ovariectomised bantam hens. Groups of
bantam hens (n=5) were injected intrav/enously with either 0.75% saline
( Q) or 50 /jo kg porcine VIP ( 221 ) • Blood samples were taken 10
minutes after injection and the plasma assayed for prolactin content in
the heterologous RIA. The results are expressed as the mean ± SEM,
(*** p^O.OOl, unpaired t-test).
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7.4 Summary and Conclusion; VIP as a specific prolactin releasing
factor
1. Neurones containing a VIP-like substance were demonstrated in the
bantam hypothalamus. These neurones were distributed in such a way
as to suggest their participation in the control of hormone secretion
from the anterior pituitary gland.
2. Porcine VIP stimulated prolactin secretion from isolated pituitary
glands from incubating birds but did not influence prolactin
secretion from pituitary glands from laying hens.
3. Porcine VIP in low doses rapidly elevated plasma levels of prolactin
when administered to nest-deprived-incubating (NDI) bantam hens.
4. Administration of porcine VIP resulted in the elevation of plasma
levels of prolactin in NDI and laying, but not in ovariectomised
bantam hens.
5. The administration of porcine VIP did not influence plasma levels of
LH,except at the highest dose in NDI birds.
6. The administration of porcine VIP to laying, NDI or ovariectomised
hens did not influence plasma levels of growth hormone.
On the basis of these results it would appear that VIP is a specific
prolactin releasing factor of possible physiological significance in the
bantam hen. The inability of porcine VIP to stimulate prolactin release
from isolated pituitary glands of laying hens suggests that the
prolactin releasing activity of porcine VIP when administered in vivo to
the laying hen may result from its action at a non-pituitary, possibly
hypothalamic, site. Alternatively, the differential effect of porcine
VIP on pituitary glands from laying and incubating birds in vitro, and
on plasma levels of prolactin in laying and incubating birds in vivo,
may be due to a change in pituitary responsiveness to VIP ,which may be
responsible for the maintenance of high plasma levels of prolactin in
incubating birds. The mechanism of this change in responsiveness may be
related to the change in ovarian steroid levels at the onset of
incubation or long-term exposure to steroids during laying. The
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facilitatory effect of ovarian steroids on the prolactin releasing
activity of VIP is suggested by the inability of porcine VIP to
stimulate prolactin secretion in ovariectomised birds.
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8.0 NEUROENDOCRINE FACTORS INFLUENCING BROODINESS IN THE BANTAM HEN
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This section summarises the principal findings in this thesis and
integrates them into a model of the neuroendocrine control of broodiness
in the bantam hen. It is acknowledged that hypothalamic
neurotransmitter/neuropeptide systems other than those examined may also
be involved in the expression of broodiness.
Figure 36 is a schematic diagram of possible neuroendocrine interactions
involved in the control of broodiness. The diagram is composed of
several major components:- a)'Hypothalamic drive', which results from
the integration of internal stimuli (via the 'higher centres') and
external (environmental) stimuli, and governs the overall activity of
the hypothalamic neuroendocrine system, b) the LHRH system, which has
been described in previous sections and is directly responsible for the
control of LH secretion, c) the prolactin-releasing-factor (PRF) system
which is directly concerned with the stimulation of prolactin secretion,
d) the anterior pituitary gland which contains the LH and prolactin
secreting cells, and e) the ovary which is the target of gonadotrophic
activity and is the source of steroid hormones.
The transition between laying and incubation is triggered by a change in
'hypothalamic drive'. This change results from the action of
environmental stimuli such as the photoperiod, the availability of a
nest site and the presence of a clutch of eggs, coupled with endogenous
stimuli resulting from a sustained period of egg production. The effect
of such a change in hypothalamic drive is to alter the hen's physiology,
through changes in the endocrine system, to permit incubation. If
incubation is sucessful the hatched young contribute further
environmental stimuli to promote brooding behaviour.
The object of this study was to elucidate the role of the hypothalamic
monoamine neurotransmitters in transforming 'hypothalamic drive' into
changes in the secretion of prolactin and LH. The role of the monoamine
neurotransmitters in the control of broodiness by the regulation of the
release of LHRH and PRF are considered first. Secondly the possible
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Figure 35: Summary of findings. The upper part of the figure is a
schematic representation of endocrine changes investigated. The
magnitude and direction of changes in monoamine turnover and putative
receptor populations, relative to those in the preceding endocrine state
are indicated by arrows.
f\W= CUv^e' icV • ?u - poster \oi
s'Tes (a- -fv.e Li vSiaC. .
- 144 -
8.1 THE ROLE OF HYPOTHALAMIC MONOAMINE NEUROTRANSMITTERS AND THEIR
RECEPTORS IN BROODINESS
The relative changes in the turnover of hypothalamic monoamines, and
changes in putative 5-hydroxytryptamine and dopamine receptors in the
hypothalamus and pituitary gland, which correlate with the endocrine
changes of broodiness are summarised in figure 35. In integrating these
findings into figure 36 it was assumed;
a) that with few exceptions the changes in monoamine functional
activity observed are related to the changes in LH and/or prolactin
secretion.
b) that the quantal relationship between receptor activation and
intracellular response,was the same in laying and incubating birds.
After the transition from laying to incubating eggs the relative
increase in the turnover of 5HT in the hypothalamus is positively
correlated with plasma levels of prolactin and inversely correlated with
plasma levels of LH. The same relationship between 5HT turnover in the
anterior hypothalamus and plasma prolactin and LH occurs in incubating
birds when they are deprived of their nests. The relative increase in
5HT turnover in the anterior hypothalamus between laying and incubating
birds may be due to the changes in putative 5HT receptor populations of
the anterior hypothalamus. In mammals a 5HT autoreceptor has been
described, which when stimulated inhibits the activity of the 5HT
neurone (Cerrito and Raiteri, 1979; Baumann and Waldmeier, 1981;
Aghajanian, 1982; Martin and Saunders-Bush, 1982). Evidence presented
earlier (section 5) suggests that a novel population of putative 5HT
receptors, located on 5HT neurones, occurs only in the anterior
hypothalamus of laying birds. If these putative receptors are
inhibitory to the function of the neurones on which they are located
then their disappearance would permit an increase in turnover similar to
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that in the incubating birds. A possible mechanism for this change in
putative receptor populations comes from studies in ovariectomised rats,
where it has been demonstrated that the level of 5HT receptors in the
anterior hypothalamus is increased by oestrogen treatment (McEwan and
accompanied by ovarian regression and a pronounced decrease in the
plasma levels of ovarian steroids (Sharp et al. 1975). If the unique
putative 5HT receptor population in the laying anterior hypothalamus was
also oestrogen dependent then this drop in steroid levels could lead to
hypothalamus of laying birds 5HT turnover is kept under a short-loop
negative feedback which is reduced at the onset of incubation.
Since the ovary is regressed in incubating bantams, it is unlikely that
the increase in plasma LH observed after short—term nest deprivation
would stimulate steroid production sufficiently to promote the
re-formation of putative 5HT autoreceptors. An alternative explanation
must therefore be found to account for the rapid decrease in 5HT
turnover in the anterior hypothalamus seen after nest—deprivation.
Possibly this is related to the dramatic change in sensory input to the
hypothalamus, mediated by unidentified higher control centres, which
alters 'hypothalamic drive'.
It is possible that changes in 5HT turnover in the anterior hypothalamus
at the onset of incubation may be associated with the inhibition of LH
secretion rather than with the stimulation of prolactin secretion.
Anatomically this suggestion is consistent with the presence of
LHRH-immunoreactive cells in this area (Sterling and Sharp, 1982) and
pharmacologically, with the effects on gonadotrophin secretion or
gonadal function, of drugs which alter 5HT function. For example,
treatment with the 5HT neurotoxin, 5,7-dihydroxytryptamine, augments
photoperiodically induced testis growth in chickens (Calas, 1975), while
drug treatments which inhibit 5HT synthesis augment, and drugs which
elevate 5HT synthesis inhibit, photostimulated testicular growth in
quail (El Halawani et al. 1978). Further, in the incubating turkey, drug
treatments which reduce 5HT synthesis result in a rise in plasma levels
Parsons, 1982) The onset of incubation in the bantam hen is
a drop in receptor levels. Thus in Figure in the anterior
- 146 -
of LH (EL Halawani et al. 1983) while pharmacological inhibition of 5HT
synthesis or the administration of the 5HT antagonist methysergide,
depresses plasma levels of LH in cockerels (Buonomo et al. 1981). These
observations are consistent with an inhibitory action of 5HT neurones on
Itthe activity of neurosecretory cells containing LHRH. Thus in Figure 35
an inhibitory pathway is shown between hypothalamic 5HT and LHRH systems
which is more prominent in the incubating than in the laying bird.
Although the turnover of 5HT and putative 5HT populations do not change
after the initiation of incubation, a rapid increase in 5HT turnover
occurs after nest-deprivation. This increase may reflect changes in the
activity of 5HT neurones in the posterior hypothalamus which are
unrelated to the control of prolactin and LH secretion. One possibility
is that it is related to a stress-induced release of ACTH. In Figure 35
the possibility of 5HT stimulation of PRF release is acknowledged by the
weak stimulatory pathway 5HT- and PRF-containing neurones.
In the anterior hypothalamus the relative turnover of dopamine is also
inversely correlated to LH secretion and positively correlated to
prolactin secretion. The possibility that dopaminergic neurones in this
area are primarily concerned with the inhibition of LH secretion, is
suggested by the decrease in hypothalamic dopamine turnover during
ovarian regression in the turkey (El Halawani and Burke, 1976) and by
the inhibitory effects of dopamine on photoperiodically induced testis
growth in the quail (El Halawani et al. 1978). However dopaminergic
neurones in the posterior hypothalamus may be involved in the inhibition
of prolactin secretion. Although the turnover of dopamine in the
posterior hypothalamus does not change after the onset of incubation,
there is a decrease in the density of putative dopamine receptors in the
pituitary gland. This change may permit the sustained secretion of the
prolactin seen in the incubating bird by decreasing the responsiveness
of the pituitary gland to the inhibitory effect of dopamine (Harvey et
al. 1982). It is possible that the decrease in putative dopamine
receptors in the pituitary may occur in response to declining levels of
ovarian steroids at the onset of incubation. This effect of oestrogen
on dopamine receptors is suggested by studies on the mammalian brain and
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pituitary gland (McEwan and Parsons, 1982). Alternatively, the apparent
decrease in putative dopamine receptors may be due to the hypertrophy of
prolactin secreting cells in the incubating bird resulting in a larger
cell membrane, with no alteration in absolute receptor concentration. On
the basis of these findings, an inhibitory pathway is suggested
between hypothalamic dopaminergic neurones and the LHRH system, and
between dopamine and prolactin containing cells in the pituitary,in
Figure ^5. An inhibitory influence of dopamine on pituitary prolactin
cells may be diminished by down-regulation of dopamine receptors in the
pituitary of the incubating bird.
The turnover of hypothalamic noradrenaline did not change after the
onset of incubation. Although noradrenaline is thought to exert a
stimulatory control over LH secretion in young chickens (Buonomo and
Scanes, 1983), the present results suggest that it is not involved in
the regulation of the endocrine events of broodiness. The significance
of the paradoxical drop in the turnover of noradrenaline in the anterior
hypothalamus after nest deprivation requires further investigation and
may be related to changed sensory input to the hypothalamus. For this
reason, a strong stimulatory pathway is suggested between noradrenergic
neurones and the LHRH system in the hypothalamus of the laying bird.
This stimulatory pathway appears to be less important in the incubating
bird.
The turnover of adrenaline in both parts of the hypothalamus was
inversely correlated with LH secretion and positively correlated with
prolactin secretion. This relationship is particularly noticeable when
comparing incubating and nest-deprived incubating birds. Although
little studied in relation to prolactin secretion and broodiness, the
activity of adrenaline containing neurones may be the basis of the
reciprocal relationship between LH and prolactin secretion. Thus, it is
possible that adrenergic neurones in the anterior hypothalamus are
inhibitory to LH secretion while adrenergic neurones in the posterior
hypothalamus stimulate prolactin secretion. For this reason an
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inhibitory pathway is suggested between adrenergic neurones and the LHRH























Figure 36: Neuroendocrine interactions in the control of broodiness. The
magnitude of an interaction is determined by size of arrow. Broken lines
represent putative interactions. Full explanation of the figure is made
in the text (p.141 etseq.)
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8.2 IDENTIFICATION OF A PHYSIOLOGICAL PROLACTIN RELEASING FACTOR:- VIP
AS A POSSIBLE CANDIDATE
In the bantam hypothalamus a VIP-like substance was located in neurones
which had an anatomical distribution consistent with a role in the
control of anterior pituitary gland function. In support of this view
porcine VIP selectively stimulated prolactin secretion from the
pituitary gland in vitro. Pituitary glands from incubating birds were
more responsive to porcine VIP than those from laying birds. The
prolactin-releasing potency of porcine VIP in vivo was also dependent on
other aspects of physiological state. Prolactin secretion was not
stimulated by porcine VIP in ovariectomised hens but was stimulated in
laying hens, and to a greater extent in incubating hens which were
deprived of their nests. These findings suggest that the sensitivity of
the pituitary gland to porcine VIP is dependent both on the releasable
pool of prolactin and on the priming effect of ovarian steroids.
Chronic exposure to high levels of ovarian steroids during a prolonged
period of laying may trigger the initial rise in prolactin secretion by
modifying the hypothalamic drive, or more specifically by altering the
balance of prolactin inhibiting and releasing factor activity. The
initial rise in prolactin secretion provokes broody behaviour, which in
turn leads to an increase in the releasable pool of prolactin in the
pituitary gland. While not excluding the possibility of a positive
short-loop feedback of prolactin on VIP neurones in the hypothalamus, an
increase in the releasable pool of prolactin probably results in an
increased pituitary sensitivity to the prolactin-releasing activity of
endogenous VIP-like material. Alternatively, the increase in the
turnover of adrenaline in the posterior hypothalamus after the onset of
incubation may stimulate the release of VIP-like material and thereby
stimulate prolactin secretion. Although further investigation is
required, the present series of experiments suggest that a VIP-like
substance is a specific physiological prolactin releasing factor in the
bantam hen. In support of this view, porcine VIP did not significantly
stimulate the secretion of either growth hormone or luteinizing hormone.
This proposition does not exclude the undoubted existence of other
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prolactin-releasing factors, but suggests that comparisons should be
made between other PRF candidates and VIP to assess further their
physiological significance.
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10.0: ANATOMICAL ABBREVIATIONS
AC anterior commissure, PIT
AL ansa lenticularis, PME
AM nucl. anterior medialis POM
hypothalami, POR
AME anterior median eminence, PPM
BC brachium conjunctivum,
magnocellularis, PVM
BPC bed nucleus of pallial PVO
commissure, QF
BT tr. bulbo-thalamicus, R
CO optic chiasma, RET
CP posterior commisure, RU
DA tr. dorso-archistriaticus, SCT
DL nucl. dorsolateralis,
DM nucl. dorsomedialis, SE
DSM decussatio supramamillaris, SM
DSO decussatio supraoptica
dorsalis and ventralis, SMD
FLM fasciculus longitudinalis
medialis, SL
HAM nucl. hypothalamicus anterior TBD
medialis, TO
HM nucl. habenularis medialis, TOM
HYP hyperstriatum, TOv
IC nucl. intercalatus, TRO
IH nucl. inferior hypothalami, TS
IN nucl. infundibuli, TSM
INC infundibular nuclear complex, TT
LC nucl. linearis caudalis, VM
LFB lateral forebrain bundle,
LHy nucl. hypothalamicus lateralis,
LT lamina terminalis,
ML nucl. mamillaris lateralis,









PHN nucl. hypothalami posterioris,
pituitary,
posterior median eminence,
nucl. praeopticus medialis,
pre-optic region,
nucl praeopticus
paraventricularis
nucl. paraventricularis,
paraventricular organ,
tr. quinto-frontalis,
Raphe
nucl. reticularis superior,
nucl. ruber,
tr. striatrotegmentalis
et stricocerebellaris,
stratum cellulare externum,
nucl. supramamillaris
interstitialis,
tr. septomesencephalicus
(dorsalis),
nucl. septalis lateralis,
tr. tecto-bulbaris dorsalis,
tr. opticus,
tr. occipitomesencephalicus,
tr. nuclei ovoidalis,
nervus trochlearis,
tr. tectospinalis,
tr. septo-mesencephalicus,
tr. tecto-thalamicus,
nucl. ventromedialis
hypothalami
